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ABSTRACT
The hippocampus is essential for long-term memory storage and consolidation.
The dentate gyrus acts as a gateway into the hippocampal formation, specifically with
reference to medial and lateral perforant path projections from the entorhinal cortex. The
dentate gyrus and the hippocampus contain a high density of cannabinoid receptors and
may be a key location in which cannabinoids exert influence to disrupt memory.
Administration of a cannabinoid agonist often leads to short-term and long-term memory
deficits in a variety of tasks.

Cannabinoids can impair memory acquisition, task

performance, along with memory consolidation and retrieval mechanisms. Endogenous
cannabinoids are retrograde messengers involved in the rapid modulation of synaptic
transmission. In the following study the effects of a potent cannabinoid agonist, WIN
55,212-2, on rodent learning and memory in the dentate gyrus were examined using a
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combination of morphological, behavioral, electrophysiological, and gene targeting
approaches.
The current study found that the cannabinoid agonist, WIN 55,212-2, altered
granule cell spine density in the dendritic targets of the associational-commissural
afferents and medial perforant path projections, but not lateral perforant path. Although
intraperitoneal injections of WIN 55,212-2 resulted in a 24-hour consolidation deficit
mediated by CB1 receptors, direct infusion of WIN 55,212-2 into the dentate gyrus did
not influence 24-hour memory consolidation or alter immediate early gene expression in
the dentate gyrus or parietal cortex. When examining in vivo electrophysiology, the
cannabinoid agonist altered perforant path to dentate gyrus responses. WIN 55,212-2
blunted the magnitude of baseline population spike amplitude, without changing baseline
fEPSP response. Furthermore, WIN 55,212-2 altered fEPSP paired pulse facilitation
indicating decreased glutamate release and impaired GABAergic inhibition. Conversely,
following high frequency stimulation, WIN 55,212-2 increased fEPSP fractional change.
And lastly, WIN 55,212-2 elevated expression of the immediate early gene Arc in the
high frequency stimulated dentate gyrus.

These findings indicate cannabinoid

modulation throughout the dentate gyrus and hippocampus is necessary for memory
consolidation processes. When taken together, these results suggest cannabinoids alter
normal learning and memory processes in the dentate gyrus by selectively altering medial
perforant path projections, changing GABAergic feedforward inhibition, reducing
glutamate release, and increasing expression of the immediate early gene Arc.
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CHAPTER 1: INTRODUCTION
Cannabis sativa has been used for centuries but despite its long history, very little
is known about its repercussions on cognition. Even though cannabis is illegal in most
countries, many people in the United States and Europe use it regularly for its medicinal
purposes and for its psychotropic effects. Recently, legislation has passed in several
states allowing cannabis to be used for pain relief and to aide in immune defense in many
debilitating illnesses such as AIDS, cancer, multiple sclerosis, and rheumatoid arthritis to
name a few (Ranganathan & D'Souza, 2006). Aside from a role in pain relief,
cannabinoid modulation is also important in processes underlying learning and memory,
appetite regulation, neuroprotection, synaptic plasticity, and retrograde signaling at
synapses (Robinson & Riedel, 2004).
Consolidation
Memory is typically described in two phases: short-term and long-term (Atkinson
& Shiffrin, 1971; Glickman, 1961; Hebb, 1949; McGaugh, 1966). Short-term (or recent)
memory is transient in nature and lasts no longer than a few minutes. Long-term (or
remote) memory is stored for weeks to years. Over time, new memories are gradually
transferred and stabilized from short-term memory stores to long-term memory stores by
a process of consolidation (Lechner, Squire, & Byrne, 1999; McGaugh, 2000; Muller &
Pilzecker, 1900). Stabilization occurs through the expression of genes and the synthesis
of new proteins which result in growth or pruning of synaptic connections (Davis &
Squire, 1984; Squire, 1986).
Traditionally, consolidation has been viewed as a finite process that occurs only
once, beginning shortly after initial learning and ending at the completion of
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consolidation hours to days later (Dudai & Morris, 2001; McGaugh, 1966; Muller &
Pilzecker, 1900).

After memory consolidation has occurred, memory is relatively

immune to forgetting and disruption, whereas memory not yet consolidated is susceptible
to interference (Duncan, 1949; Squire, 1992). Regardless of when the exact transition
between short-term and long-term memory occurs, researchers generally agree that (1)
different stages involve different levels of cascade activation with only long-term storage
requiring gene expression, and (2) synaptic consolidation is universal, found in all
species, preparations, and memory tasks (Dudai & Morris, 2001).
Role of CB1 receptors & endocannabinoids in learning & memory
The pharmacological analysis of the cannabinoid system started in 1964 when
two chemists, Gaoni and Mechoulam, first isolated the psychoactive component of
marijuana, delta-9-tetrahydrocannabinol (THC), using column chromatography and mass
spectrometry to elucidate its chemical structure (Julien, 2005). An important
breakthrough in understanding the target on which THC acts occurred in 1988 when
Howlett and colleagues discovered the first cannabinoid receptor (Julien, 2005). Soon
after its discovery and with the rise in genetic technology, the cannabinoid receptors were
cloned, endocannabinoids were discovered and cannabinoid receptor knockout mice were
generated. Since then abundant knowledge has flooded the scientific literature regarding
the pharmacology of the cannabinoid system. The term cannabinoid, originally used to
describe a 21-carbon substance found in cannabis plant extracts, is now used to define
any compound that is specifically recognized by the cannabinoid receptor.
Cannabinoids, both endogenously and exogenously produced, signal through a
distinct set of receptors: CB1 and CB2 receptors. CB1 receptors are located in the central
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nervous system and in parts of the peripheral nervous system, while CB2 receptors are
found predominately in the peripheral nervous system where they assist in immune
regulation and endogenous opioid release. CB1 receptors are coupled with inhibitory Gi
proteins and are heterogeneously expressed in the central nervous system with
particularly high concentrations in the cerebral cortex, hippocampus, cerebellum, basal
ganglia, brainstem, thalamus, and hypothalamus (Pertwee, 1997; Pertwee & Ross, 2002).
The presence of CB1 receptors throughout the basal ganglia and cerebellum are primarily
responsible for the movement and postural disturbances seen with cannabinoid
administration, while their presence in the hippocampus is responsible for memory
disturbances, and their presence in the cortex, especially the frontal cortex, is responsible
for perceptional disturbances while taking cannabinoid agonists (Robinson & Riedel,
2004). CB2 receptors have a low overall homology with CB1 receptors and are found
primarily in immune cells. Although recently, it was reported that CB2 receptors exist in
the CNS, as well as a potential yet undetermined and unnamed CB3 receptor which
possess a slight level of binding to cannabinoid agonists (Hashimotodani, Ohno-Shosaku,
& Kano, 2007).
CB1 receptors are predominately localized on presynaptic terminals where they
modulate the release of several neurotransmitters, primarily gamma-aminobutyric acid
(GABA) and glutamate, but also dopamine, epinephrine, or norepinephrine, depending on
location (Pertwee & Ross, 2002; Riedel & Davies, 2005; Robinson & Riedel, 2004). In
the hippocampus and neocortex, CB1 receptors are expressed by a defined subpopulation
of GABAergic interneurons (Katona et al., 1999), as well as by hippocampal
glutamatergic neurons (Katona et al., 2006) where they act as glutamate release
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inhibitors. They exert their modulatory influence by inhibiting Ca2+ currents, facilitating
K+ channel gating, inhibiting adenylyl cyclase and the subsequent activation of the MAP
kinase pathway and other signaling cascades which regulate gene expression
(Chevaleyre, Takahashi, & Castillo, 2006). The CB1 receptor has been shown to have a
high level of constitutive activity or ligand-independent activation (Howlett et al., 2011).
The property of constitutive activity is essential for the receptor to maintain a
cannabinoid tone in the central nervous system and also permits the receptor to be
modulated not only by agonists, but also by inverse agonists.
Effects of cannabinoid agonists on memory
Cannabinoids impair a wide range of spatial memory tasks selectively hindering
task acquisition, consolidation, and retention. In the Morris water task (MWT), a single
dose of cannabinoids has been shown to impair task acquisition initially (Ferrari,
Ottanim, & Giuliani, 1999), impair 24-hour consolidation (Candelaria-Cook, 2009), and
impair long-term/one month consolidation (Yim, Hong, Ejaredar, McKenna, &
McDonald, 2008). In other memory tasks cannabinoid administration also results in
memory impairment. Working memory is impaired in the radial arm maze (Nakamura,
da Silva, Concilio, Wilkinson, & Masur, 1991), T-maze (Suenaga, Kaku, & Ichitani,
2008), and delayed-match-to-sample tasks (Heyser, Hampson, & Deadwyler, 1993).
Memory retrieval is impaired in the radial arm maze (Wegener, Kuhnert, Thuns, Roese,
& Koch, 2008) and object recognition memory is impaired following novel object
placement (Schneider & Koch, 2002). However, there is one type of learning that is
enhanced, not diminished, by cannabinoid administration. In extinction learning
cannabinoids facilitate the rate of extinction following fear conditioning (Pamplona,
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Bitencourt, & Takahashi, 2008; Pamplona, Prediger, Pandolfo, & Takahashi, 2006) and
also facilitate reversal learning in the MWT (Pamplona, et al., 2006).
Following chronic treatment cannabinoid receptors and the cannabinoid system
exhibits tolerance to some of the memory impairing disruptions in tasks [MWT
acquisition (Boucher et al., 2009), delayed-match-to-sample (Deadwyler, Heyser, &
Hampson, 1995), object recognition (Schneider & Koch, 2003), and extinction (Lin,
Mao, Chen, & Gean, 2008)] but not all tasks [MWT reversal (Boucher, et al., 2009),
radial arm maze (Stiglick & Kalant, 1982), or T-maze (Nava, Carta, Colombo, & Gessa,
2001)]. It is possible that tolerance to all memory impairments would develop after a
long duration of cannabinoid administration (i.e., a treatment period over 30 days) given
that the studies which found significant tolerance used longer administration protocols
(delayed-match-to-sample, objection recognition).
Cannabinoids have also been shown to impair both long-term potentiation (LTP)
(Collins, Pertwee, & Davies, 1995; Hill, Froc, Fox, Gorzalka, & Christie, 2004;
Nowicky, Teyler, & Vardaris, 1987; Terranova, Michaud, LeFur, & Soubrie, 1995) and
long-term depression (LTD) (Misner & Sullivan, 1999), thereby altering long lasting
synaptic plasticity in a significant manner. A modulatory role for endocannabinoids in
LTD was first shown in dorsal striatal neurons, where LTD was facilitated by blocking
cellular endocannabinoid uptake, while LTD was impaired in CB1 receptor knockout
mice (Gerdeman, Ronesi, & Lovinger, 2002). Since then, endocannabinoid modulated
LTD has also been shown in the nucleus accumbens, basolateral amygdala, hippocampus,
neocortex, and cerebellum (Hashimotodani, et al., 2007). Besides a role in modulating
LTD in various regions, endocannabinoids have also been implicated in hindering LTP.
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CB1 receptor knockout mice have enhanced LTP in the Schaffer collateral-CA1 pathway
when compared to wild type controls (Bohme, Laville, Ledent, Parmentier, & Imperato,
2000). It has also been shown by Lawston et al. (2000) that treatment with WIN 55,2122 resulted in shorter, disjointed dendrites in the CA1 region which could account for the
observed decrements in LTP. But, it may be the case that the reduction in LTP is due to
reduced glutamate transmission (Shen, Piser, Seybold, & Thayer, 1996; Sullivan, 2000).
By inhibiting glutamatergic responses, they may be indirectly impacting normal LTP, and
possibly changing gene expression underlying the neural mechanisms of long term
memory storage. It is possible that cannabinoids may be producing deficits by either
modulating glutamate or GABA, however, cannabinoids are coupled more highly to
GABA in a ratio of 20:1, and therefore are most likely modulating a deficient
GABAergic response (De Oliveira Alvares, Genro, Diehl, Molina, & Quillfeldt, 2008).
CB1 receptors are modulatory in nature and impact numerous neurotransmitters
and responses throughout the brain. It is recognized that due to the fact that cannabinoids
are found regulating several neurotransmitter systems throughout the brain, they will
have numerous functions, not solely functions pertaining to memory. The exact
mechanism behind the cannabinoid deficit in spatial learning remains unclear.
Cannabinoid receptors are coupled to G-proteins that inhibit adenylyl cyclase. In general,
stimulation of adenylyl cyclase activity promotes learning via activation of protein kinase
A, whereas inhibition of adenylyl cyclase inhibits learning. It is important to note that
this is a generalization, and that, in some instances, receptors that are negatively coupled
to adenylyl cyclase promote learning.
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CHAPTER 2: OBJECTIVES
Rationale
Exposure to exogenous cannabinoids can have vast negative repercussions on
cognitive systems by altering underlying neurocircuitry permanently. Acute and longterm abuse of cannabinoids in rats leads to deficits in memory processing (Ferrari, et al.,
1999; Robinson et al., 2008; Yim, et al., 2008), neuronal cell death (Katona, et al., 2006),
detrimental neuronal cellular changes (Robinson & Riedel, 2004; Sullivan, 2000), and
changes in dendritic morphology (Kolb, Gorny, Limebeer, & Parker, 2006; Rubino et al.,
2009). Recent studies have shown that the cannabinoid agonist WIN 55,212-2 impairs
rodent spatial memory consolidation in the Morris Water Task (MWT) (CandelariaCook, 2009; Yim, et al., 2008) and this impairment is mediated by CB1 receptors
(Candelaria-Cook & Hamilton, 2010).

When these deficits in MWT short-term

consolidation (Candelaria-Cook, 2009) are taken together with previous finding that WIN
55,212-2 impairs long-term consolidation processes in the MWT (Yim, et al., 2008) it
becomes evident further research is needed to investigate the specificity and mechanisms
behind the response.

Thus, identifying the conditions in which disruption of

consolidation processes does or does not have deleterious effects on memory represent
important contributions to learning and memory research.
Hypothesis
Spatial memory consolidation deficits are seen when exogenous cannabinoid
agonists are administered due to deficient signaling within the hippocampal dentate
gyrus. Further, the consolidation deficits are due to CB1 receptors directly reducing the
amount of glutamate and GABA release from the presynaptic cell, thereby reducing
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synaptic signaling. Cannabinoid receptors alter the release of glutamate from mossy cells
and GABA from basket cells (see Figure 1). By disrupting synaptic signaling and
impairing feedforward and feedback inhibition, the cannabinoid induced memory
impairment should manifest itself on various physiological and behavioral levels.
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Figure 1: Dentate gyrus signaling pathways. Cannabinoids may negatively impact the
medial perforant path and associational-commissural projection afferents onto the dentate
granule cell. Cannabinoids decrease glutamate release from mossy cells and decrease
GABA release from basket cells. Abbreviations: LPP, lateral perforant path; MPP,
medial perforant path; A-CP, associational-commissural projection; (+), excitatory
synapse; (-), inhibitory synapse.
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Specific aims
In order to address the role of cannabinoids in spatial memory consolidation the
following aims were developed to address the regional specificity of a specific behavioral
response, underlying physiology, and functional activity:

Aim 1: To address regional specificity for a cannabinoid induced deficit in spatial
memory consolidation by examining the hippocampal dentate gyrus. The dentate
gyrus acts as a gateway into the hippocampal formation, specifically with regards to
medial and lateral perforant path projections from the entorhinal cortex; and therefore,
may be a key location cannabinoids exert influence to disrupt memory.
•

Experiment 1.1: Evaluate differences in dendritic morphology of the

lateral perforant path, medial perforant path, and commissural/associational path
into the hippocampal dentate gyrus following chronic cannabinoid agonist WIN
55,212-2 administration.
•

Experiment 1.2: Evaluate 24-hour consolidation in the MWT following

direct infusion of the cannabinoid agonist WIN 55,212-2 via cannulation into the
hippocampal dentate gyrus.
Aim 2: To address changes in physiology that may account for a cannabinoid
induced deficit in spatial memory consolidation by examining effects of
cannabinoids on synaptic plasticity. This aim will explore how cannabinoids impact a
physiological marker of plasticity critically involved in long-term cellular memory
formation.
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•

Experiment 2.1: Evaluate changes to long-term potentiation in vivo (pop-

spike amplitude, decay) following medial and lateral perforant path to dentate
gyrus stimulation with the cannabinoid agonist WIN 55,212-2 on board.
Aim 3: To address functional activity changes that may account for a cannabinoid
induced deficit in spatial memory consolidation by examining neurotransmitter
release and signal transduction pathways. By changing neurotransmitter release and
signal transduction pathways CB1 receptors may be critically involved in dampening
neuronal signals to foster forgetting naturally in the body.
•

Experiment 3.1: Evaluate paired pulse facilitation ratios following long-

term potentiation in vivo to gather information regarding glutamate and GABA
transmission (Aim 2).
•

Experiment 3.2: Evaluate expression of immediate early gene products

(Arc, cFos, zif268) by quantitative RT-PCR to address differences in signal
transduction pathways following cannabinoid administration and MWT training
(Aim 1.1) and long-term potentiation (Aim 2).
Significance
The set of experiments outlined above will investigate the effect of an exogenous
cannabinoid agonist on spatial memory consolidation using a range of experimental
techniques, which will capture systems levels phenomena down to cellular level
phenomena. When taken together, these findings should reveal how cannabinoids are
detrimental to long-term memory formation, consolidation and storage in the brain.
These studies will also inform the role of CB1 receptors in hippocampal circuitry.
Although it is widely known CB1 receptors are densely packed in the dentate gyrus, their
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exact function remains mysterious. It is possible that CB1 receptors interact with their
endogenous ligands, anandamide and 2-AG, after synaptic activity to modulate
consolidation and produce the natural process of forgetting.

Given the scarcity of

information regarding the effects cannabinoids have on long-term memory processes, the
proposed study will provide important and novel information which may be used to
inform drug policy and/or establish treatments for cognitive disorders.
Distribution of specific aims across chapters
The effects of cannabinoid administration on consolidation of spatial memory
will be assessed in three aims that cumulatively investigate the regional specificity,
physiology and functional activity changes induced by cannabinoid administration. To
benefit publication purposes the five experiments will be combined into three concise
dissertation chapters. Cannabinoid regional specificity will be broken down into two
chapters. A portion of Aim 1 will be addressed in Chapter 3 (Experiment 1.1) which
focuses on dendritic morphology of various pathway projections from the entorhinal
cortex, specifically the lateral perforant path, medial perforant path, and associatecommissural path that terminate in the upper blade of the dentate gyrus. The second part
of Aim 1 will be addressed in Chapter 4 (Experiment 1.2), which focuses on 24-hour
consolidation in the MWT following direct infusion of WIN 55,212-2 into the dorsal
dentate gyrus. Aim 2 examining the effects of cannabinoids on electrophysiology, will
be addressed in Chapter 5 (Experiment 2.1), which examines the effect WIN 55,212-2
has on LTP following medial perforant path-to-dentate gyrus stimulation.

Aim 3

examining the effects of cannabinoids on functional activity changes in the dentate gyrus
will be found in Chapters 4 and 5 combined with their respective experimental
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manipulation. The differences in immediate early gene products (Arc, cFos, and zif268)
following MWT behavior can be found in Chapter 4, while the differences following
induction of LTP can be found in Chapter 5. Chapter 5 also contains Experiment 3.1 of
Aim 3, which evaluates differences in GABAergic and glutamatergic transmission via
paired pulse ratios.

Figure 2: Aims distributed across chapters. The three aims are located in various
sections of chapters 3-5.
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CHAPTER 3: DENTATE GYRUS REGIONAL SPECIFICITY PART ONE
(DENDRITIC MORPHOLOGY)
The region of interest to investigate the cannabinoid influence on memory
consolidation is the hippocampus. The focus is on the hippocampus because this region
contains the highest density of CB1 receptors, has a well-defined synaptic circuitry,
expresses several forms of well-studied synaptic plasticity, and is critically involved in
spatial memory. The dentate gyrus acts as a gateway into the hippocampal formation,
specifically with regards to medial and lateral perforant path projections from the
entorhinal cortex (Figure 3); and therefore, may be a key location cannabinoids exert
influence to disrupt memory. It is assumed that after the medial perforant path and lateral
perforant path circulate the entire hippocampus, the transformations it undergoes are
presumably essential for long-term memory storage and consolidation.
In order to assess the morphological changes in these projections produced by
cannabinoid administration, a chronic administration model will be used as changes to
dendritic morphology and spine density take repeated administration over time to
produce. An acute dose of cannabinoids would not be sufficient to produce the type of
dendritic morphological change captured by the Golgi-Cox technique. It should be noted
though, that the overall goal of these Golgi-Cox studies is to assess changes in
hippocampal dentate gyrus regional specificity following cannabinoid agonist exposure
and changes to specific regional projections.
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Figure 3: Line drawing of dentate gyrus connectivity. [Adapted from Johnston &
Amaral (2004)]. Projections from the entorhinal cortex target specific regions of dentate
dendritic branches. Granule cell axons and mossy fibers project to CA3 and the A-CP of
unilateral and contralateral hemispheres. GABAergic basket cells (B) are located in the
granule cell layer, while glutamatergic mossy cells (M) are located in the polymorphic
layer. Abbreviations: m, molecular layer; g, granule cell layer; p, pyramidal cell layer; pl,
polymorphic layer; LPP, lateral perforant path; MPP, medial perforant path; A-CP,
associational-commissural projection
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Chronic cannabinoid agonist (WIN 55,212-2) exposure alters hippocampal dentate
gyrus spine density in adult rats
Accepted to Brain Research on October 20th, 2013
Abstract
Chronic abuse of drugs can result in vast negative repercussions on behavioral
and biological systems by altering underlying neurocircuitry. Long-term cannabinoid
administration in rats leads to detrimental cellular and dendritic morphology changes.
Previous studies have found that chronic treatment with delta-9-THC selectively
decreases dendritic morphology and spine density in the dentate gyrus of adolescent rats
(Rubino, et al., 2009); however, whether these changes are specific to a particular
developmental age is not known. The present study evaluated the effects of chronic
exposure (7 or 21 days) to WIN 55,212-2 (i.p., 3.7 mg/kg), a potent cannabinoid agonist,
on dendritic morphology of dentate gyrus neurons in adult rats. Upon completion of
treatment brains were processed for Golgi-Cox staining. No significant effects of WIN
55,212-2 exposure were observed for dendritic branching or length. Spine density was
quantified in the inner (proximal), middle, and outer (distal) thirds of the dendritic fields
selected to approximate the spatial loci of afferents comprising the associationalcommissural pathway, medial perforant path, and lateral perforant path, respectively.
Compared to vehicle controls there was a significant reduction in spine density (~1
spine/10 µm) in the inner and middle dendritic segments. The spine density reduction was
significant in inner segments following 7 days of treatment. These results suggest that
chronic cannabinoid treatment specifically alters spine density in the dendritic targets of
the associational-commissural afferents and medial perforant path projections, but not
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lateral perforant path. The resulting loss of dendritic spine density may be an important
factor underlying cannabinoid induced memory impairments.
Introduction
Long-term exposure to exogenous cannabinoids can result in persistent changes to
dendritic morphology and spine density (Kolb, et al., 2006; Rubino, et al., 2009).
Changes to dendritic morphology represent potential mechanisms by which cannabinoid
exposure may influence behavioral and cognitive processes.

Previous studies have

demonstrated that chronic treatment with delta-9-tetrahydrocannabinol (THC) after 10-12
days selectively alters dendritic morphology of neurons depending on developmental age
and region of interest.

In adolescent rats THC administration altered dendritic

morphology of dentate gyrus granule cells (Rubino, et al., 2009), while in adult rats THC
administration increased dendritic morphology of medium spiny neurons of the nucleus
accumbens shell and pyramidal neurons of the medial prefrontal cortex with no changes
to the CA1 field of the hippocampus, striatum, orbital frontal cortex, parietal cortex, or
occipital cortex (Kolb, et al., 2006). Accompanying the changes in granule cell dendritic
morphology (i.e., lowered dendritic length, branching, spine density) produced by
chronic exposure to cannabinoids in adolescence, Rubino et al. (2009) found deficits in
spatial working memory in a radial arm maze, decreased protein expression (GFAP,
VAMP2, PSD95) and NMDA receptor levels across the hippocampus. When taken
together, previous studies imply chronic cannabinoid abuse in adolescence results in
decreased synaptic plasticity and long-term cognitive deficits in adulthood. The impact of
cannabinoids with use beginning in adulthood remains an open area of research, as little
has been reported in this area. Whether the pattern of hippocampal alterations seen by
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Rubino et al., (2009) is observed in adult animals that begin cannabinoid use in adulthood
has yet to be determined. Also, given that previous differences in dendritic morphology
were found with THC, it is pertinent to see if the effects generalize to other cannabinoid
agonists with different receptor binding affinities.
Cannabinoid administration induces memory deficits in a wide assortment of
behavioral paradigms (Riedel & Davies, 2005). The most commonly reported outcomes
of cannabinoid use or exposure are pronounced short-term memory deficits (Robinson &
Riedel, 2004) mediated by CB1 receptors in the CA1 region of the hippocampus (Wise,
Thorpe, & Lichtman, 2009). Cannabinoids also disrupt long-term spatial memory storage
by interfering with memory consolidation processes mediated by CB1 receptors in the
dorsal hippocampus (Yim, et al., 2008). It is likely CB1 receptors in other regions of the
hippocampal formation modulate other forms of memory and consolidation processes.
The dentate gyrus acts as a gateway into the hippocampal formation, specifically
with regard to medial and lateral perforant path projections from the entorhinal cortex
that represent major neocortical afferents into the hippocampus, and therefore, may be a
key location cannabinoids exert influence to disrupt memory. Mossy cells of the dentate
hilus contain the highest levels of CB1 receptors amongst excitatory hippocampal neurons
(Kawamura et al., 2006; Monory et al., 2006). There is also a dense representation in the
inner third of the molecular layer of the dentate gyrus (Katona, et al., 2006), which
corresponds spatially to the associational-commissural projection, where mossy cells
form synapses onto dendrites of the granule cells (Johnston & Amaral, 2004). Afferents
to dentate gyrus granule cells also include the medial perforant path and lateral perforant
path projections from the entorhinal cortex, which form synapses in the middle third and
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outer third (distal) of the granule cell dendritic fields. The medial and lateral entorhinal
inputs have been shown by Hargreaves et. al. (2005) to relay different types of
information, with spatial information conveyed by the medial perforant path and nonspatial information conveyed by the lateral perforant path. It is important to further
understand the role cannabinoids have on the dentate gyrus as this region contains the
highest density of CB1 receptors, has well-defined synaptic circuitry and synaptic
plasticity, and is critically involved in spatial memory consolidation.
The present study was designed to examine changes in dendritic morphology
produced by chronic treatment with a potent cannabinoid agonist WIN 55,212-2. The
drug treatment began once the animals were mature adults (six months of age), which
distinguishes this study from previous reports. Adult rats were given daily intraperitoneal
(i.p) injections of WIN 55,212-2 or vehicle for 7 or 21 days after which the brains were
processed for Golgi-Cox staining. Dendritic branching and length were quantified in
granule cells sampled from the medial portion of the upper blade of the dentate gyrus,
Zilles’ area DG, Figure 4 (Zilles, 1985). By focusing on the spatial distribution of dentate
gyrus afferents, it is also possible to infer how cannabinoids impact various hippocampal
projections and their targets. Toward this goal, spine density was quantified in segments
sampled from the inner, middle and outer thirds of the dendritic fields, relative to the
soma, to estimate changes in the targets of the associational-commissural projection,
medial perforant path projection, and lateral perforant path projection, respectively
(Figure 5).
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Figure 4: Dentate gyrus coronal sections. Coronal sections [adapted from Zilles
(1985)] showing the region from which dentate granule cells were drawn. Sampling
occurred in the upper blade of the dentate gyrus (DG), highlighted in gray, in sections
ranging from 3.3 mm to 3.8 mm posterior to Bregma.
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Figure 5: Granule cell divisions.
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(A) For spine analysis the dentate granule cell

dendritic field was divided into three layers (proximal, middle, and distal) to correspond
to major afferent pathways: A-CP (ssociational-commissural pathway), MPP (medial
perforant path), and LPP (lateral perforant path). (B) Example illustrating the staining
quality of granule cell spines (1200X magnification).
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Experimental procedures
Animals
Subjects were 24 male Long-Evans rats acquired from Harlan Laboratories
(Indianapolis, IN). All rats were six months of age at the beginning of experiment. Rats
were pair-housed in standard clear plastic cages and maintained in a temperature and
humidity controlled vivarium with food and water available ad libitum. The University of
New Mexico Institutional Animal Care and Use Committee (IACUC) approved all
experimental procedures.
Drugs treatments
The cannabinoid agonist WIN 55,212-2 (Sigma-Aldrich), was dissolved in 5%
DMSO (Sigma-Aldrich) with 0.1% Tween 80 (Sigma-Aldrich) and brought to volume
with sterile Dulbecco’s phosphate buffered saline (Sigma-Aldrich). WIN 55,212-2 was
prepared at a concentration of 3.7 mg/mL. The control solution consisted of the drug
vehicle. Both drug and vehicle solutions were prepared daily and injected at a volume of
1 mL/kg of body weight.

All drug doses and vehicle preparations were selected

according to previous literature (Pamplona, et al., 2006; Pamplona & Takahashi, 2006;
Schneider, Drews, & Koch, 2005; Yim, et al., 2008). The rats were divided into four
experimental groups (n = 6): 7 day vehicle, 7 day WIN, 55-212-2, 21 day vehicle, and 21
day WIN 55,212-2. Shortly after the beginning of the light cycle (1000 h), rats were
weighed in the colony room and given an i.p. injection of WIN, 55, 212-2 or vehicle
control, once daily, for 7 or 21 days. Rats were immediately returned to their cage
following injection.
Golgi-Cox staining and analysis
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At the conclusion of the experiment, one day following their last injection, rats
were given an overdose of sodium pentobarbital and perfused transcardially with 0.9%
(w/v) saline. The brains were extracted and immediately immersed in 30 mL of GolgiCox solution (Glaser & Van der Loos, 1981) for 14 days, followed by immersion in 30%
(w/v) sucrose for three days. Coronal sections, 200 µm thick, were cut on a vibrating
blade microtome, mounted on 2% gelatinized slides, stained, dehydrated, cleared, and
cover slipped, as described by Gibb and Kolb (1998).
Granule cells of the dentate gyrus, Zilles’ area DG (Zilles, 1985), were selected
for analysis from the medial portion of the upper blade (Figure 4). An Olympus light
microscope (Model BX51) equipped with a drawing attachment was used for analysis.
Five neurons from each hemisphere (10 neurons per rat) were traced using the camera
lucida technique (250X magnification). Selection was limited to unobscured, complete,
and well-impregnated neurons with representative dendritic morphology for the region of
interest. Sampling included sections ranging from 3.3 mm to 3.8 mm anterior to Bregma.
An experimenter blind to drug conditions performed all morphology, spine tracing, and
analysis.
Dendritic branching was measured by counting bifurcations on each dendrite
(Coleman & Riesen, 1968). First-order branches were dendritic segments prior to the first
bifurcation from the soma and branch order was incremented by one for each subsequent
bifurcation on a given dendritic branch. The number of first through sixth-order (and
higher) branches was quantified and an estimate of total branches was determined from
these values. Dendritic length was measured using the Sholl analysis (Sholl, 1981). A
printed transparency of a series of 20 µm concentric ring intersections (calibrated to 250X
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final magnification) was centered over the cell body and the total number of intersections
between each ring and dendritic branch was counted. The Sholl values were converted to
estimates of dendritic length as a function of distance from the soma.
For spine density analysis, each dendritic branch was divided into three different
segments at various distances from the cell body: an inner (proximal) segment, middle
segment and outer (distal) segment (see Figure 5). Each segment was approximately 50
µm in length. These divisions were selected to correspond to the three major afferent
pathways projecting into the dentate gyrus: associational-commissural path, medial
perforant path, and lateral perforant path, correspondingly. Selection was limited to
branches for which all three segments were continuous (i.e., not uninterrupted by a
branch point). Spine density was measured by tracing each dendritic segment at high
power (2000X magnification) followed by tracing all spines present in each segment.
Total spine density per 10 µm was calculated from these values. Spine density was
quantified on 10 granule cells, five cells per hemisphere. Mean spine density was
calculated on 10 measurements per segment, three segments per cell. The unit of analysis
for each rat was mean spine density for the entire dendritic field or for each layer.
Results
Analyses of Variance (ANOVAs) were performed using SPSS (version 20 for
Macintosh). All test statistics reported here were significant at p < 0.05 unless otherwise
noted. For all analyses Drug condition (vehicle, WIN 55,212-2) and Exposure length (7
day, 21 day) were between-subjects factors. Within-subjects factors included in separate
ANOVAs for branch order, length, and spine density were distance from soma (Sholl
analysis), branch order, or segment (spine density only). Effect sizes (partial eta squared;
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ηp2 ) are reported for all effects. One vehicle animal was identified as an outlier with
respect to spine density quantification and excluded from analysis as its spine density
values were greater than three standard deviations below the group mean, consistent with
suboptimal staining. There were a total of 23 brains included in analyses of dendritic
length, branching, and spine density (11 vehicle and 12 WIN 55,212-2).
Dendritic length and branching
Mean dendritic branching and length are presented in Figure 6A and B. Because
there were no significant effects involving duration of exposure, the data were collapsed
over this factor to simplify presentation of the results. There were no significant main
effects or interactions for branch order [all ps > 0.355] or total branches [MVEH = 22.317,
MWIN = 22.042, all ps > 0.439]. There were also no significant main effects or
interactions with distance from soma for dendritic length [all ps > 0.226], or for total
dendritic length [MVEH = 32.891, MWIN = 33.725, all ps > 0.275].
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Figure 6: Dendritic branching and length group means. Mean (+SEM) of total
branches for first through sixth (and greater) branch orders (A) and dendritic length as a
function of distance from the soma (B) for vehicle and WIN 55,212-2 exposed rats.

	
  

25	
  

	
  
	
  

Spine density
Mean spine density for the three segments of interest: inner, middle, and outer
thirds (association-commissural path, medial perforant path, and lateral perforant path,
respectively), in the dentate gyrus are presented in Figure 7. Because there were no
interactions involving duration of exposure and drug treatment the data were collapsed
over levels of exposure duration to simplify presentation of the results. The Segment X
Drug interaction approached significance [F(2, 38) = 3.126, p = 0.055, ηp2 = 0.141].
Inspection of the means suggests that WIN 55,212-2 exposure reduced spine density on
the order of 1 spine per 10 microns in the inner and middle segments. Comparisons of
the drug groups for each segment revealed significant differences for the inner segment
[F(1, 21) = 5.511, p = 0.029, ηp2 = 0.208] and middle segment [F(1, 21) = 4.661, p =
0.043, ηp2 = 0.182], but not the outer segment [p = 0.557].
In addition, there was a main effect of Segment [F(2, 38) = 17.106, ηp2 = 0.474],
which was due to increased spine density in the middle segment compared to each of the
other two segments [all ps < 0.0004]. There was also a significant interaction between
Segment X Exposure duration [F(2, 38) = 9.775, ηp2 = 0.340]. Rats that received
injections (vehicle or drug administration) for 7 days had greater spine density in the
inner segment than rats that received injections for 21 days [M7d = 15.876, M21d = 14.750,
F(1, 21) = 6.704, ηp2 = 0.242]. No other main effects or interactions were significant.
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Figure 7: Dendritic spine density group means. Dentate granule cell dendritic field
spine density in vehicle and WIN 55,212-2 exposed rats: (A) Representative camera
lucida drawings of the cell layers from each group (1200X magnification), (B) Mean
(+SEM) spine density from the inner, middle, and outer segments, corresponding to the
Associational-Commissural Pathway, Medial Perforant Path, and Lateral Perforant Path
(respectively). WIN 55,212-2 exposed rats had lower spine density in inner and middle
segments compared to Vehicle controls [*p<0.05].
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Discussion
Long-term cannabinoid administration was associated with a marked reduction in
dendritic spine density within granule cells of the dentate gyrus. More specifically, the
spine density loss (1 spine per 10 µm) was limited to the inner and middle dendritic
segments of the granule cell, which correspond spatially to targets of the associationalcommissural afferent and medial perforant path afferent, respectively. These observations
do not reflect a generalized reduction in overall dendritic morphology, as no differences
were found between drug and vehicle groups in measures of dendritic length and
branching, but instead indicate select spine sensitivity in spatially relevant afferents from
the entorhinal cortex following long-term cannabinoid exposure. When taken together,
these results suggest long-term WIN 55,212-2 treatment specifically alters targets of the
associational-commissural path and medial perforant path afferent from entorhinal cortex
but not the lateral perforant path.
A previous study that examined dendritic morphology after long-term THC
exposure in adolescence found reductions in dendritic branching, length and spine density
in the dentate gyrus that persisted into adulthood (Rubino, et al., 2009). The current study
extends these findings by showing that spine loss in the dentate gyrus also occurs in adult
rats that began chronic treatment in adulthood after the brain was fully matured;
therefore, some changes in dendritic morphology following long-term cannabinoid
administration are not specific to a particular developmental age. Conversely, the fact that
we did not find differences in overall dendritic branching and length in adult rats implies
that adolescent granule cells may be more sensitive to cannabinoids. There is clear
evidence for adolescent cannabinoid sensitivity that results in persistent, long-term
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decreases in hippocampal dendritic morphology, protein expression, NMDA receptor
levels, and deficits spatial working memory (Rubino, et al., 2009). Given that the
negative consequences observed after adolescent exposure far outnumber the effects
observed after mature adulthood exposure, there is an indication that hippocampal
cannabinoid sensitivity may be partially resolved by adulthood. In fact, cannabinoidinduced structural plasticity was only found in specific circuits (associationalcommissural path and medial perforant path) within the hippocampus and only in relation
to spine density within those circuits. Reductions in overall dendritic branching and
length in adult rats might have been expected given the reductions in spine density;
however, no significant reductions in branching or length were observed. One possibility
is that the lack of spine density reductions in the most distal (outer) portions of the
granule cell dendritic fields helped prevent overall reductions in length and branching.
Taken together with the current observations, the marked reductions in branching and
length that have been reported in adolescent rats suggest that granule cells are more
sensitive to cannabinoids prior to adulthood.
Another study that examined dendritic morphology following long-term THC
exposure in adult rats found increased dendritic morphology on medium spiny neurons of
the nucleus accumbens and pyramidal neurons of the medial prefrontal cortex and a lack
of drug differences in pyramidal neurons in the CA1 field of the hippocampus (Kolb, et
al., 2006). These authors did not investigate morphology differences in the dentate gyrus,
but taken together the available data indicate that regionally specific changes within the
hippocampus and hippocampal formation occur following long-term cannabinoid
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exposure. Potentially, increases in dendritic morphology in other brain regions may
compensate for reductions in dendritic spine density in the dentate gyrus.
The current study also provides evidence that a different cannabinoid agonist
WIN 55,212-2, with higher binding affinities for the CB1 receptor than THC, produces
similar changes in dendritic morphology following long-term administration; therefore,
the changes in dendritic morphology may be a consequence of all cannabinoid agonists.
Previously it was shown that WIN 55,212-2 administration elevated spine densities in the
zebra finch song regions, area X and XVC, following long-term exposure (Gilbert &
Soderstrom, 2011); thus, future studies should further examine alterations in spine
density in different brain regions following exposure to WIN 55,212-2.
The current study examined differences in dendritic morphology 24 hours after
the last drug injection. With this design it is possible to examine the immediate changes
produced by WIN 55,212-2, but it remains unknown if the effects are long lasting, and
more research is needed to verify the persistence of spine density changes observed
following exposure and withdrawal. Previous cannabinoid research using THC by Kolb
et al. (2006) and Rubino et al. (2009) found the morphology changes produced by
cannabinoids to be long lasting and persistent even after several weeks of withdrawal
(from one to two months). Therefore, it is likely the WIN 55,212-2 spine density
alterations are long-lasting. Although following cocaine treatment Kolb et al. (2003)
found that persistence of spine alterations (in this case enhancements) varies depending
on drug treatment regiment, which may also play an important role in the persistence of
changes observed with cannabinoids.
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Due to the fact that there is a dense band of CB1 receptors present in the lower
layer of the dentate gyrus stratum moleculare (Katona, et al., 2006) this area is likely to
be impacted by long-term cannabinoid exposure. This region also corresponds to the
ipsilateral associational-commissural projection originating from axons of the mossy cells
of the hilus that form excitatory synapses back onto granule cells creating a feedback
loop to regulate dentate gyrus responsiveness (Johnston & Amaral, 2004; Laurberg &
Sorensen, 1981). Interestingly, endocannabinoids have been shown to signal at
glutamatergic synapses on dendritic spines throughout the hippocampus. Katona et. al.
(2006) found that diacylglycerol lipase α, the precursor to 2-arachidonoyl-glycerol, is
highly concentrated on the heads of dendritic spines indicating involvement with
retrograde signaling at glutamatergic synapses to presynaptic CB1 receptors. Expanding
on these results, Uchigashima et. al (2011) showed that within the dentate gyrus
specifically, mossy cells contained abundant presynaptic CB1 receptors and granule cell
spines released 2-arachidonoyl-glycerol forming a bridge for retrograde signaling to
adjust network activity in the dentate gyrus following excitation. If the CB1 receptors are
located at the end of a mossy cells synapses releasing glutamate onto granule cell spines,
following exogenous cannabinoid agonist stimulation the Gi/o coupled CB1 receptor
would prevent glutamate release and the postsynaptic spine may retract due to loss of
excitation.
Within the associational-commissural afferents may also be where exogenous
cannabinoids are most disruptive by creating feedback inhibition disruption.

If

cannabinoids inhibit mossy cell excitation of proximal granule cell dendrites following
feedback inhibition, the end result may be reduced excitation of the granule cell, reduced
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synaptic plasticity, and reduced hippocampal dependent learning and memory. Given that
the medial perforant path is involved in long-term potentiation following high frequency
stimulation of entorhinal inputs, the medial perforant path is a critical site of memory
processing into the hippocampus. It has been shown that during high frequency
stimulation of the medial perforant path in vivo, CB1 activation increases glutamate
release from perforant path synapses while inhibiting release of GABA from local
interneurons (Sokal, Bennetti, Girlanda, & Large, 2008). Additionally it has been shown
that medial perforant path stimulation preferentially recruits inhibitory basket cells in a
feedforward fashion, bypassing excitatory granule cell inputs and feedback inhibition
(Ewell & Jones, 2010). The cumulative effects of cannabinoids on these processes may
contribute to the pattern of spine density loss observed here.
Alterations in spine density resulting from long-term cannabinoid exposure in
adult rats may be an important contributing factor underlying behavioral findings of
cannabinoid induced memory impairment and memory consolidation deficits. Segment
specific changes in spine density may have important consequences for spatial learning
and memory processes in the dentate gyrus, especially considering the pattern of
reductions observed here. Hargreaves et. al. (2005) showed that the medial perforant
path transferred spatial information from the medial entorhinal cortex, while the lateral
perforant path transferred nonspatial information. Alterations in the synaptic targets of
medial perforant path projection in the dentate gyrus may contribute to spatial learning
and memory impairments, possibly through reductions in processes involved in
consolidation of spatial information. WIN 55,212-2 given post-training in the Morris
water task impaired long-term spatial memory consolidation by activating CB1 receptors
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in the dorsal hippocampus (Yim, et al., 2008). Prior work from our laboratory found
similar Morris water task post-training administration consolidation deficits following a
24-hour consolidation time frame (Candelaria-Cook, 2009; Candelaria-Cook & Hamilton,
2008). We also found that the WIN 55,212-2 spatial memory consolidation deficit could
be recovered by administration of the cannabinoid antagonist AM 251 (Candelaria-Cook
& Hamilton, 2010), further supporting the role of CB1 receptors in spatial memory
consolidation. Future research should examine the relationship between cannabinoid
induced reductions in spine density and memory consolidation. One prediction derived
from the present data would be that cannabinoids may have a more profound effect on
spatial memory consolidation than consolidation of non-spatial information processed via
the lateral perforant path.
A few limitations of the current study should be taken into consideration. The
present study evaluated dendritic morphology only within the dentate gyrus and its
afferents. It is likely that different, yet complementary changes in morphology exist in
other regions of the hippocampus and in other regions of the brain, as indicated by Kolb
et al. (2006). The present study was also limited to analysis of males. Future work
should address if sex differences exist in granule cell dendritic morphology. The present
study was also limited to one WIN 55,212-2 drug dose. A high dose was selected based
on previous literature on cannabinoid-induced deficits on spatial memory. While the
results obtained here with a high dose of cannabinoids were limited to spine density, in
the future different doses ranging from low to high should be investigated.
In summary, the present findings demonstrate a significant reduction in dendritic
spine density of the dentate gyrus following long-term administration of WIN 55,212-2 in

	
  

33	
  

	
  
	
  

adult rats. This loss in spine density on the granule cells was specific to the portions of
the dendritic fields that receive associational-commissural afferents from within the
hippocampal formation and medial perforant path afferents from the entorhinal cortex,
and did not generalize to overall changes in dendritic length and branching. Given the
involvement of granule cell plasticity in memory, these observations suggest exposure to
exogenous cannabinoids can have profound and long-lasting effects on long-term spatial
memory storage and consolidation.
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CHAPTER 4: DENTATE GYRUS REGIONAL SPECIFICITY PART TWO
(CANNULATION)
The dentate gyrus is a critical component of the hippocampal formation that
bridges connections from the entorhinal cortex to the hippocampus proper. By acting as
a relay board, the dentate gyrus has the potential to alter all information that enters the
hippocampus; therefore, the dentate gyrus has the potential to alter the initial processes
underlying memory consolidation and memory storage. Given its potential role in
memory consolidation, the dentate gyrus is the primary focus of the following studies on
regional specificity of cannabinoid-induced deficits in spatial memory consolidation.
In earlier experiments (Candelaria-Cook, 2009) it was found that cannabinoid
administration (via intraperitoneal injections) impaired spatial memory acquisition and
consolidation in a hidden platform version of the Morris water task (MWT). First, using
the Repeated Acquisition Procedure (Keith & Galizio, 1997), 16 rats were given daily
injections over 10 days of WIN 55,212-2 (3.7 mg/kg) or vehicle prior to beginning the
MWT to address potential learning and sensorimotor deficits produced when the
cannabinoid agonist is on board and the rat is performing the MWT. Rats that received
WIN 55,212-2 had a significant learning/acquisition deficit across all days of training, as
indicated by longer latencies and routes taken to reach the platform. These rats also had
an initial performance deficit during the first three to four days of MWT training,
indicating WIN 55,212-2 impacted the rat’s ability to swim and perform the MWT
normally; however, all sensorimotor deficits exhibited quick tolerance and by the end of
the 10 days of training WIN 55,212-2 rats had equivalent performance to vehicle
controls. The second experiment assessed the role of cannabinoids on memory
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consolidation by giving the drug immediately post-training, thereby avoiding acquisition
confounds. In this experiment, 32 rats received WIN 55,212-2 or vehicle injections
immediately following fixed platform MWT training and memory was assessed 24 hours
later by a non-reinforced probe and four trials of retraining. Rats that received the
cannabinoid agonist showed reduced memory for the platform location when compared
to vehicle controls indicating a significant 24-hour consolidation deficit during the
memory probe and first trial of retraining (Figure 8). Through these sets of experiments
cannabinoids were to shown to impair acquisition and consolidation, with minimal
disturbance to performance in the MWT. Because these experiments were performed
with i.p. injections, further research was needed to investigate receptor specificity for this
cannabinoid-induced memory loss.
A follow-up study (Candelaria-Cook & Hamilton, 2010) showed that the MWT
consolidation deficit was mediated by CB1 receptors. Immediately following MWT
training rats were given either: vehicle, WIN 55,212-2, AM 251, or a combined WIN
55,212-2 + AM 251 i.p. injection. When the cannabinoid antagonist (AM 251) was given
30 minutes prior to cannabinoid agonist (WIN 55,212-2), the antagonist blocked the
memory impairment of the agonist. When given alone, the cannabinoid agonist (WIN
55,212-2) impaired 24-hour consolidation similar to original findings, Figure 8H.
Meanwhile, the antagonist alone (AM 251) had no impact on consolidation. This brief
follow-up study was able to determine receptor specificity for the cannabinoid-induced
memory loss in the MWT. The focus now turns to determining regional specificity for the
cannabinoid-induced consolidation deficit. Given the role of the dentate gyrus in memory
formation and knowing WIN 55,212-2 can alter spine density in this region (Chapter 3),
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perhaps the dentate gyrus is also a region critical for cannabinoid-induced memory
consolidation deficits.
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Figure 8: Post-training cannabinoid administration impairs 24-hour consolidation
via CB1 receptors. Morris water task probe and retraining measures following 24-hour
consolidation showing WIN 55,212-2 impairment of retention path length and latency.
WIN 55,212-2 rats had impaired memory for previous platform location (* denotes p <
0.05).
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Post-training cannabinoid agonist intrahippocampal infusion does not influence
spatial memory consolidation.
Abstract
Cannabinoids have repeatedly been shown to be detrimental to the maintenance of
learning and memory processes. A previous study by Yim et al. (2008) reported that an
infusion of WIN 55,212-2 into dorsal hippocampus disrupted long-term spatial memory
in the Morris water task. The present study evaluated if cannabinoid infusion of WIN
55,212-2, a potent cannabinoid agonist, into the dentate gyrus produced similar results
and disrupted short-term 24-hour spatial memory consolidation processes. WIN 55,212-2
(10 µg/µL), AM 251 (40 µg/µL)+WIN 55,212-2 (10 µg/µL), or vehicle was bilaterally
infused into the dorsal dentate gyrus. WIN 55,212-2 or vehicle was bilaterally infused
into the parietal cortex immediately following Morris water task training. Upon
completion of behavior, brains were processed for immediate early gene expression and
cannula placement verification.

The data suggest WIN 55,212-2 delivered into the

dentate gyrus or parietal cortex had no impact on 24-hour memory consolidation, as
memory retention was comparable to vehicle controls during the MWT probe test.
Interestingly, the combination infusion of AM 251 followed by WIN 55,212-2 30
minutes later did impair consolidation as seen by impaired probe latency, path length and
2nd trial of retraining measures. Further, WIN 55,212-2 did not alter immediate early
gene expression in the dentate gyrus or parietal cortex. This behavioral data is contrary
to earlier findings using systemic injections. This indicates that it is likely another region
of the hippocampal formation, or the summation of all hippocampal areas working
together
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neuromodulation in the dentate gyrus is necessary but not sufficient to produce
cannabinoid-induced memory impairments.
Introduction
Cannabinoids are widely known to be detrimental to processes underlying normal
learning and memory. The most commonly reported cannabinoid-induced deficit is
impaired working memory. It known that CB1 receptors in the CA1 region of the
hippocampus are important for short-term memory deficits (Wise, et al., 2009).
Following cannabinoid agonist administration working memory is impaired in the radial
arm maze (Nakamura, et al., 1991), T-maze (Suenaga, et al., 2008), and delayed-matchto-sample tasks (Heyser, et al., 1993). CB1 agonists have been shown to impair a wide
range of spatial memory tasks selectively hindering acquisition, consolidation, and
retention. In the Morris water task (MWT), a single dose of cannabinoids has been
shown to impair task acquisition initially (Ferrari, et al., 1999), impair 24-hour
consolidation (Candelaria-Cook, 2009; Candelaria-Cook & Hamilton, 2008, 2010) and
impair long-term/one month consolidation (Yim, et al., 2008). Due to cannabinoidmediated acquisition deficits, memory consolidation must be studied with a post-training
design. It is likely that CB1 receptors in other regions of the hippocampal formation
modulate other forms of memory and consolidation processes.
Using a post-training administration design, prior work from our laboratory found
that a single systemic dose of WIN 55,212-2 resulted in a 24-hour short-term
consolidation deficit in the MWT (Candelaria-Cook, 2009; Candelaria-Cook & Hamilton,
2008). A deficit which could be recovered by administration of the cannabinoid
antagonist AM 251 (Candelaria-Cook & Hamilton, 2010), further supporting the role of
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CB1 receptors in spatial memory consolidation.

Yim et al. (2008) found similar

consolidation deficits in the MWT with systemic injection of WIN 55,212-2, although
they found the consolidation deficit one month following training and not one week after
training, concluding cannabinoids impacted long-term consolidation processes. Yim et
al. (2008) further showed regional specificity for the cannabinoid consolidation deficit
with post-training intracranial microinfusions of WIN 55,212-2.

Inspection of the

hippocampal cannula placements used by Yim et al. (2008) determined the authors
targeted regions CA1 and dentate gyrus of the dorsal hippocampus. From these studies
(Candelaria-Cook, 2009; Candelaria-Cook & Hamilton, 2008, 2010; Yim, et al., 2008) it
is clear the cannabinoid agonist WIN 55,212-2 can impair short and long-term
consolidation processes.

Further, it has been shown that the memory consolidation

disruption is mediated by CB1 receptors, however the specific brain regions or systems
responsible remain unidentified. It remains unknown if other regions of the hippocampus
are involved in the cannabinoid-induced consolidation deficit, or if the deficit is solely
driven by cannabinoid modulation within region CA1 of the hippocampus.
It is important to further understand the role cannabinoids have on the dentate
gyrus because mossy cells of the dentate hilus contain the highest levels of CB1 receptors
amongst excitatory hippocampal neurons (Kawamura, et al., 2006; Monory, et al., 2006).
The dentate gyrus is also is critically involved in spatial memory consolidation. Medial
entorhinal inputs and the medial perforant path terminate in the middle portion of the
upper blade of the dentate gyrus and contain spatial information (Hargreaves, et al., 2005)
which is sent to the other regions of the hippocampus. Lesions to the medial perforant
path input into the dentate gyrus result in impaired place learning in the MWT suggesting
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medial perforant path terminals have a higher efficiency in activating hippocampal
neurons (Ferbinteanu, Holsinger, & McDonald, 1999). Lesions to the dentate gyrus
result in impaired MWT acquisition and delayed matching-to-place tasks when compared
to lesions of other hippocampal subregions (Okada & Okaichi, 2009). Lee & Kesner
(2002) suggest the different hippocampal subregions are important for different parts of
spatial memory, with CA1 and dentate gyrus important for memory acquisition and longterm retrieval and CA3 important for reorganization of spatial representation. However,
it may be that all subregions of the hippocampus act as a functional unit for spatial
memory and all regions are necessary for proper memory consolidation (Okada &
Okaichi, 2009). Whether one part of the hippocampus is more important for memory
consolidation remains to be seen.
Immediate early genes (IEGs) are named for their rapid response to cellular
stimuli. There are several involved in various components of cellular signaling pathways,
but three IEGs in particular are of interest to memory consolidation researchers: Arc
(Activity-dependent cytoskeleton associated protein), cFos, and zif268. Arc has been
shown to play an important role in behavioral plasticity, when Arc expression is blocked
there is interference with consolidation of spatial memory within granule cells (Guzowski
et al., 2000). Guzowski et al. (2001) found correlations between the IEGs Arc, cFos, and
zif268 and memory consolidation with the MWT. Specifically, they found that Arc is the
most responsive IEG to differences in behavioral task demands and Arc mRNA levels
were correlated with learning in hippocampal-dependent versions of the MWT. In other
tasks of spatial exploration, following environment specific spatial exploration Arc
expression within the upper blade of the dentate gyrus exhibits a four-fold increase over
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control animals (Chawla et al., 2005). Aside from Arc, other IEGs are also important for
memory consolidation. Zif268 is known to be essential for memory consolidation and is
involved in the expression of long-term memories (Jones et al., 2001). In zif268 knockout
mice early phases of LTP are normal, but later phases of LTP underlying consolidation
are not present; therefore, 24-hour consolidation issues arise (Bozon, Davis, & Laroche,
2002).
The present study was designed to examine the impact of a potent cannabinoid
agonist (WIN 55,212-2) on spatial memory consolidation and resulting immediate early
gene expression (Arc, cFos, and zif268) within the hippocampal dentate gyrus.
Immediately following MWT training, a high-dose intrahippocampal infusion of vehicle,
WIN 55,212-2, AM 251+WIN 55,212-2, targeting the upper blade of the dentate gyrus,
was given to adult rats. Memory retention was tested 24-hours later with a no-platform
probe and four trials of retraining. In the first subset of rats, IEG mRNA levels were
measured in the dentate gyrus four hours after MWT behavioral training. In the second
subset of rats, cannula locations within the dentate gyrus were verified with fluorescent
muscimol imaging. Together, these manipulations should reveal if the dentate gyrus is
important for cannabinoid-induced memory consolidation deficits and if certain IEGs
within the dentate gyrus are changed following cannabinoid exposure.
Experimental procedures
Animals
Subjects were 36 male Long-Evans rats acquired from Harlan Laboratories
(Indianapolis, IN). All rats were three months of age at the beginning of the experiments.
Rats were pair-housed in standard clear plastic cages and maintained in a temperature and
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humidity controlled vivarium with food and water available ad libitum. The University
of New Mexico Institutional Animal Care and Use Committee (IACUC) approved all
experimental procedures.
Drug treatments
All drug doses and vehicle preparations were selected according to previous
literature (Lichtman, Dimen, & Martin, 1995; Yim, et al., 2008). WIN 55,212-2 (SigmaAldrich) was prepared for microinfusion at a high dose concentration of 10 µg/µL in
vehicle solution. AM 251 (Tocris) was prepared for microinfusion at a high dose
concentration of 40 µg/µL in vehicle solution (Sink et al., 2009). The vehicle solution
consisted of a 1:1:18 ratio ethanol:alkamuls:saline, respectively. WIN 55,212-2 was first
dissolved and vortex in a 1:1 mixture of ethanol and alkamuls EL-620 (kindly provided
by Rhodia Pharma Solutions). The mixture brought to volume with 18 parts sterile
Dulbecco’s phosphate buffered saline (Sigma-Aldrich), vortex and sonicated. AM 251
was first dissolved and vortex in a 1:1 mixture of ethanol and alkamuls. The mixture
brought to volume with 18 parts sterile Dulbecco’s phosphate buffered saline, vortex, and
sonicated. All drug and vehicle solutions were prepared fresh daily.
Microinfusions
Rats were divided into five experimental groups: 10-Veh/DG, 11-WIN/DG, 5AM 251+WIN/DG, 5-Veh/PC, and 5-WIN/PC. Immediately following the last MWT
training trial on day one, within three to five minutes, all rats received a direct cannula
infusions over two unilateral infusions, altering hemisphere order. Rats in the antagonist
condition received the antagonist initially following training followed 30 minutes later by
the agonist. For infusions, animals were gently held in a towel by the experimenter while
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the infusion cannula (Plastics One) was attached to the implant via a connector assembly
(Plastics One). The infusion cannula was attached to polyethylene tubing (PE20) and
connected to a 10 mL Hamilton syringe (Hamilton Company) controlled by a Stoelting
microinfusion pump. The Stoelting microinfusion pump was set at a rate of 0.5 µL/min
for one minute.

Each infusion cannula extended 1.0-2.5 mm below the implanted

cannula tip, depending on region, parietal cortex and dentate gyrus, respectively. Infusion
cannula was left in place for an additional two minutes to allow for drug diffusion. The
extent of diffusion was estimated, based on fluorescent imaging, to be one mm radially
from the cannula tip. Prior to the start of each experiment, all rats were handled and
wrapped in a towel several times to habituate to the infusion procedure.
Cannulation
Animals were anesthetized with isoflurane (4%) oxygen mixture in an induction
chamber for surgical preparation and placed into a stereotaxic frame (David Kopf
Instruments) with anesthetic administered via facemask. Once a surgical plane of
anesthesia was achieved, the isoflurane concentration was reduced to 2%. After cleaning
the scalp, a midline incision was made to expose the skull. Holes were drilled using a
dental burr at the following coordinates relative to Bregma for bilateral implants into
dorsal hippocampus: AP -4.0, ML ±3.5, and for parietal cortex: AP -3.5, ML±3.5
(Paxinos & Watson, 2005).

Sterile guide cannulas (Plastics one; 26-gauge) were

implanted by stereotaxic guidance so that the guide tip was located for dentate gyrus at:
AP -4.0, ML ±3.5, DV -1.9, and for parietal cortex at: AP -3.5, ML ±3.0, DV -1.0
(Paxinos & Watson, 2005). The cannulas were permanently fixed in dental cement with
five small jewelers’ screws as anchors for stability. All animals were given
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buprenorphrine subcutaneously every 12 hours after surgery for analgesia 48 hours and
individually housed for the duration for the experiment. Animals were allowed to recover
for two weeks before behavior testing.
Morris water task
The procedure for the Morris water task was modified from the original
guidelines outlined by R. G. M. Morris (Morris, 1981, 1982, 1984). The apparatus was a
circular swimming pool (1.5 m in diameter) located in a room with various distal visual
cues. The pool was filled with water, maintained at 25°C, and made opaque by the
addition of a small amount (~2 oz.) of nontoxic white tempera paint. Inside the pool, a
removable rectangular Plexiglas platform (12 cm x 12 cm) was submerged to a depth of 1
cm below the surface of the water. The platform was located in a defined quadrant of the
maze (NE, NW, SE, and SW). Four release points were used and the sequence of release
points was determined by a pseudorandom sequence. Each trial consisted of releasing the
rat into the water facing the outer edge of the pool and letting the rat escape to the
platform before 60 seconds elapsed. The rat’s swimming behavior was videotaped by an
overhead camera and transferred to a computer workstation for tracking and analysis.
All rats received MWT pre-training a few days prior to MWT training and testing.
The pre-training was done in a separate room from the actual testing room to provide a
distinct learning environment and consisted of 12 trials during one day. The MWT pretraining was necessary to ensure rats learned the non-specific aspects of the task (e.g.,
that escape cannot be achieved at the pool wall, and that there is an escape platform).
MWT pre-training also guaranteed all rats could effectively solve the task before further
experimental manipulations. All were at asymptotic performance after pre-training.
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MWT training occurred over the course of a single day with 12 fixed platform
trials. The trials were massed with one-minute inter-trial-intervals. Each rat was run
individually to minimize training duration and control initiation of consolidation.
Immediately following the last training trial, rats were wrapped in a towel and infused
with either vehicle, WIN 55,212-2, or AM 251+WIN 55,212-2 then returned to their
home-cage. Twenty-four hours later, the rat’s memory of the platform location was
tested with a 60 second probe trial followed by four trials of retraining.
Twenty-three rats underwent a second round of MWT testing one week later (see
experimental timeline in Figure 9B). A new room and pool position were used to create a
novel environment.

To provide various IEG controls rats were divided into three

experimental groups to account for swimming behavior only, drug only, and combination
swimming behavior and drug conditions (MWT/NoDrug, NoMWT/Veh1hemiWIN1hemi,
MWT/Veh1hemi WIN1hemi).

Rats were unilaterally infused with vehicle into one

hemisphere and drug into the second hemisphere to provide a within subjects measure for
IEG analysis. Rats in the swimming behavior only condition received 12 massed trials of
MWT and were returned to their home-cage. Rats in the drug only condition were taken
to the novel MWT environment but did not receive MWT testing. Instead, drug only rats
were wrapped in a towel and received infusions of vehicle into one hemisphere and WIN
55,212-2 into the other hemisphere and returned to their home-cage.

Rats in the

combination swimming and drug condition were given 12 massed trials and immediately
infused with vehicle into one hemisphere and WIN 55,212-2 into the other hemisphere in
a pseudorandom order. No retention tests were performed for any of the animals; four
hours later rats were euthanized for IEG expression.
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Figure 9: Experimental timeline for cannulation. Rats were divided into two cohorts
following MWT retention tests. FCM cannula verification was performed on 13 rats (A),
while a second round of behavioral training and IEG quantification was performed on 23
rats (B).
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Immediate early gene expression
IEG quantification was performed on 23 rats not involved in FCM cannula
verification (Figure 9B). Four hours following experimental manipulation (swimming
only, drug only, combination swimming and drug condition) rats were rapidly
anesthetized in an isoflurane chamber and euthanized. The brain was quickly extracted,
and placed in ice-cold phosphate buffered saline. The brains were visually inspected for
proper cannula placements. The dentate gyrus and parietal cortex were micro-dissected,
placed in RNA free tubes, and stored at -80 °C. Quantitative real-time polymerase chain
reaction (qRT-PCR) was performed according to a previous protocol (Caldwell et al.,
2008) and Arc, cFos, zif268 mRNA levels were measured using primers designed by Dr.
Clark Bird. Primers were designed from national database sequences of rat reference
mRNA and validated with NCBI primer BLAST software. First, mRNA was extracted
from the stored tissue using a RNeasy mini kit (Qiagen) and mRNA concentration was
determined using a NanoDrop spectrophotometer (NanoDrop Technologies). cDNAs
were created using 1 µg total mRNA and Superscript II Reverse Transcriptase (Invitrogen
Corporation) following manufacturer’s protocol and stored at -20 °C until used. qRTPCR reactions were performed on an Applied Biosystems 7100 Real Time PCR System
using 96-well plates (Applied Biosystems). Gene expression levels were analyzed using
SYBR Green (Life Technologies) detection in triplicate reactions against GAPDH values.
Based on dissociation curves, abnormal samples were discarded. Relative levels of IEG
(Arc, cFos, and zif268) expression compared to control GAPDH expression were
calculated using the 2-
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Cannula placement verification with fluorophore-conjugated muscimol
Cannula verifications were performed on the 13 remaining rats not involved in
IEG quantification (Figure 9A). Following previous protocols (Allen et al., 2008;
Stackman, Lora, & Williams, 2012) 1 mg of fluorophore-conjugated muscimol (FCM)
(BODIPY TMR-X; Invitrogen) was dissolved in 1 mL of Dulbecco’s phosphate buffered
saline (Sigma Aldrich), sonicated and aliquotted for storage. Rats were anesthetized with
isoflurane (4%) oxygen mixture in an induction chamber and placed in a stereotaxic
frame (David Kopf Instruments) with anesthetic administered via facemask. Infusion
cannula (Plastics One) targeting hippocampal dentate gyrus (2.5 mm extension below
implant) and parietal cortex (1.0 mm extension below implant) were attached to
polyethylene tubing (PE20), connected to a 10 mL Hamilton syringe (Hamilton
Company) controlled by a Stoelting microinfusion pump.

Rats received bilateral

intracranial microinfusions of FCM at a rate of 0.5 µL/min for two minutes. Infusions
were confirmed by monitoring fluid flow in the tubing via a small bubble. Infusion
cannula was left in place for an additional two minutes to allow for drug diffusion. One
hour following FCM infusion, rats were euthanized with an overdose of isoflurane.
Brains were removed, frozen in isopentane chilled in a dry-ice/methanol bath and stored
at -80 °C. Brains were sliced into 40 µm thick coronal sections with a freezing microtome
and mounted onto 2% gelatinized slides. Sections were briefly air-dried then fixed in 4%
buffered paraformaldehyde for 20 minutes. Slides were cover-slipped using fluorescent
glue and stored at -4 °C until image processing.
To visualize the locations of infusion cannula tips and quantify the spread of
FCM, fluorescent images were acquired on an Olympus microscope (Model BX51)
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equipped with a fluorescent lamp and digital camera (Olympus Model DP70) attached to
a personal computer. Images were acquired at 20X magnification with FITC filter sets
(Olympus). Exposure times were manually adjusted to maximize image quality and
visualize area of fluorescence. Proper placement of cannulas within the dentate gyrus
was confirmed. All brains sectioned from rats with hippocampal cannulation showed
cannula placement in the upper blade of the dentate gyrus, Figure 10. Example FCM
images of distribution within the dentate gyrus are shown in Figure 11. Proper placement
of cannulas within the parietal cortex was confirmed. All brains sectioned from rats with
parietal cortex cannulation showed cannula placement in the dorsal portion of the medial
parietal association cortex and lateral parietal association cortex, Figure 12. Example
FCM images of distribution within the parietal cortex are shown in Figure 13. No
animals were excluded from behavioral analysis due to improper cannula placement.
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Figure 10: Placement of cannulas within the dentate gyrus. Coronal sections [adapted
form Paxinos and Watson (2005)] showing proper placement of cannulas within the
dentate gyrus. All brains sectioned showed infusion sites and infusion cannula tip
placement in the upper blade of the dentate gyrus.
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Figure 11: Muscimol verifications of dentate gyrus cannula placement. Fluorescent
images of hippocampal coronal sections at 40X magnification showing FCM infusion site
distribution within the left and right hemispheres, respectively. Images confirm FCM was
infused and distributed into the upper blade of the dentate gyrus.
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Figure 12: Placement of cannulas within the parietal cortex. Coronal sections
[adapted form Paxinos and Watson (2005)] showing proper placement of cannulas within
the parietal cortex. All brains sectioned showed infusion sites and infusion cannula tip
placement in the dorsal portion of the medial parietal association cortex and lateral
parietal association cortex.
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Figure 13: Muscimol verifications of parietal cortex cannula placement. Fluorescent
images of parietal cortex coronal sections at 40X magnification showing FCM infusion
site distribution within the left and right hemispheres, respectively. Images confirm FCM
was infused and distributed into the dorsal portion of the medial parietal association
cortex and lateral parietal association cortex.
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Results
Analyses of Variance (ANOVAs) were performed using SPSS (version 22 for
Macintosh). All test statistics reported here were significant at p < 0.05 unless otherwise
noted. A total of 36 rats were analyzed for MWT behavior (10 Veh-DG, 11 WIN-DG, 5
AM-DG, 5 Veh-PC, 5 Veh-PC). For IEG analysis 23 brains were used (7 MWT only, 5
Drug only, 8 DG infusion, 3 PC infusion). For the Drug only, DG infusion, and PC
infusion conditions, vehicle was infused into one hemisphere and WIN 55,212-2 into the
second hemisphere. Separate ANOVAs were conducted for various experimental
components: MWT training, MWT retention, IEG. Effect sizes (partial eta squared; ηp2 )
are reported for all effects.
MWT- dentate gyrus microinfusion
Training. To evaluate group differences in the training data prior to experimental
manipulation, swim data was analyzed in a two-way mixed model ANOVA with drug
condition (vehicle, WIN 55,212-2, AM 251+WIN 55,212-2) as the between-subjects
factor and trial block as within subject factor. There was a significant main effect of Trial
on latency [F(11,253) = 5.614, ηp2 = 0.196] and path length [F(11,253) = 6.652, ηp2 =
0.224]. Follow-up contrasts revealed significant linear trends for latency [F(1,23) =
16.276, ηp2 = 0.414] and path length [F(1,23) = 18.802, ηp2 = 0.450] indicating that
latency and path length to reach the platform decreased across training trials. No other
main effects or interactions were significant ps> 0.823. All drug groups were equivalent
in performance at the end of training, Figure 14.
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Figure 14: MWT training latency and path length- dentate gyrus. MWT behavior
prior to dentate gyrus infusions: (A) mean latency to platform (±SEM), (B) mean path
length to platform (±SEM). There were no significant differences between groups during
training.
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Probe. To evaluate 24-hour consolidation following post-training dentate gyrus
microinfusion, 30 second no-platform probe swim data was analyzed by univariate
ANOVAs with latency to reach target location, average proximity of entire swim path to
target location, path length to reach target location, percent time in target quadrant, and
number of target location crosses as dependent measures, Figure 15. There was a
significant main effect of Drug in latency to target location [F(2,23) = 4.963, ηp2 = 0.301]
and path length to target location [F(2,23) = 6.121, ηp2 = 0.347]. Follow-up pairwise
comparisons revealed AM 251+WIN 55,212-2 rats had significantly higher latency to
target location and significantly longer path lengths to target location compared to vehicle
and WIN 55,212-2 rats representing impaired retention. This suggests the cannabinoid
antagonist AM 251 in combination with WIN 55,212-2 microinfused into the dentate
gyrus impaired 24-hour consolidation and memory retention. The main effect of Drug in
average distance to target location approached significant [F(2,23) = 3.303, p = 0.055, ηp2
= 0.223]. Follow-up pairwise comparisons revealed WIN 55,212-2 rats had significantly
shorter average distances to target location compared to vehicle and AM 251+WIN
55,212-2 rats. This indicates rats that received the cannabinoid agonist WIN 55,212-2 had
more precise searching behavior than vehicle controls and the cannabinoid antagonist
AM 251+WIN 55,212-2. There were no further differences between drug groups, ps>
0.146. When taken together, the data indicates microinfusion of the cannabinoid agonist
WIN 55,212-2 into the dentate gyrus did not impair memory consolidation, and in fact
search precision was improved in one measure of probe performance, while the
cannabinoid antagonist AM 251+WIN 55,212-2 impaired memory retention.
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Figure 15: MWT no-platform probe test- dentate gyrus. Probe dependent measures
evaluating memory for former platform location 24 hours following drug infusion into
dentate gyrus (+SEM): (A) latency to reach target location, (B) average proximity of
entire swim path to target location, (C) path length to reach target location, (D) percent
time in target quadrant, (E) number of target location crosses. AM 251+WIN 55,212-2
rats had impaired latency and path length (* denotes p < 0.05). WIN 55,212-2 rats had
more precise search behavior demonstrated by shorter average distance from target (†
denotes p = 0.055).
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Retraining. To further evaluate 24-hour consolidation following post-training
dentate gyrus microinfusion, four trials of retraining were analyzed in a two-way mixed
model ANOVA with drug condition (vehicle, WIN 55,212-2, AM 251+WIN 55,212-2) as
the between-subjects factor and trial block as within subject factor. Overall, there were
no significant main effects or interactions. The primary trial of interest was the first trial
of retraining, immediately after the MWT probe; however, no differences between drug
groups existed during retraining Trial 1. There was a Trial X Drug interaction that was
approaching significance for latency [F(6,69) = 2.170, p = 0.056, ηp2 = 0.159] and path
length [F(6,69) = 1.919, p = 0.090, ηp2 = 0.143]. Follow-up pairwise comparisons
revealed that AM 251+WIN 55,212-2 rats had significantly higher latencies than vehicle
and WIN 55,212-2 rats during the second retraining trial, Figures 16 C&D. Meanwhile,
the difference between WIN 55,212-2 rats and vehicle rats during the first retraining trial
approached significance (p = 0.095), Figures 16 A&B. All drug groups were equivalent
in performance by the end of retraining.
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Figure 16: MWT retraining latency and path length- dentate gyrus. MWT behavior
24 hours after dentate gyrus infusions evaluating memory for former platform location
(±SEM): (A) mean latency to platform (±SEM), (B) mean path length to platform
(±SEM). There were no significant differences between groups during retraining.
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MWT- parietal cortex microinfusion
Training. To evaluate if group differences existed in the training data prior to
experimental manipulation, swim data was analyzed in a two-way mixed model ANOVA
with drug condition (vehicle, WIN 55,212-2) as the between-subjects factor and trial
block as within subject factor. There was a significant main effect of Trial on latency
[F(11,88) = 4.356, ηp2 = 0.353] and path length [F(11,88) = 4.470, ηp2 = 0.358]. Followup contrasts revealed significant linear trends for latency [F(1,8) = 37.912, ηp2 = 0.826]
and path length [F(1,8) = 61.511, ηp2 = 0.885] indicating that latency and path length to
reach the platform decreased across training trials. There was a significant Trial X Drug
interaction on latency [F(11,88) = 2.099, ηp2 = 0.208] and path length [F(11,88) = 2.173,
ηp2 = 0.214]. Follow-up Helmert contrasts revealed Trial 1 and Trial 3 were significantly
different than remaining trials in terms of latency [F(1,8) = 5.358, ηp2 = 0.401, F(1,8) =
7.342, ηp2 = 0.479, Trial 1 & 3, respectively] and path length [F(1,8) = 5.897, ηp2 =
0.424, F(1,8) = 5.271, ηp2 = 0.397, Trial 1 & 3, respectively]. Although rats were
assigned to drug conditions based on MWT pre-training performance to equate the drug
groups, WIN 55,212-2 rats showed impaired latency and path length initially. However,
by the end of training there was no difference between groups. No other main effects or
interactions were significant ps > 0.146.
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Figure 17: MWT training latency and path length- parietal cortex. MWT behavior
prior to parietal cortex infusions: (A) mean latency to platform (±SEM), (B) mean path
length to platform (±SEM). There were no significant differences between groups by the
end of training.
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Probe. To evaluate 24-hour consolidation following post-training parietal cortex
microinfusion, 30 second no-platform probe swim data was analyzed by univariate
ANOVAs with latency to reach target location, average proximity of entire swim path to
target location, path length to reach target location, percent time in target quadrant, and
number of target location crosses as dependent measures. There were no significant
differences between vehicle and WIN 55,212-2 rats in any of the probe measures, ps >
0.105. Microinfusion of WIN 55,212-2 into the parietal cortex did not impact memory
consolidation or influence memory retention.
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Figure 18: MWT no-platform probe test- parietal cortex. Probe dependent measures
evaluating memory for former platform location 24 hours following drug infusion into
the parietal cortex (+SEM): (A) latency to reach target location, (B) average proximity of
entire swim path to target location, (C) path length to reach target location, (D) percent
time in target quadrant, (E) number of target location crosses. There was no significant
difference between groups in platform memory retention. Microinfusion of WIN 55,2122 into the parietal cortex did not impact memory consolidation or influence memory
retention.
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Retraining. To further evaluate 24-hour consolidation following post-training
parietal cortex microinfusion, four trials of retraining were analyzed in a two-way mixed
model ANOVA with drug condition (vehicle, WIN 55,212-2) as the between-subjects
factor and trial block as within subject factor. No main effects or interactions were
significant, ps > 0.167. There were no significant differences between groups at any trial
of retraining. Both drug groups were equivalent in performance during retraining.
Microinfusion of WIN 55,212-2 into the parietal cortex did not impact memory
consolidation or influence memory retention.
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Figure 19: MWT retraining latency and path length- parietal cortex. MWT behavior
24 hours after parietal cortex infusions evaluating memory for former platform location
(±SEM): (A) mean latency to platform (±SEM), (B) mean path length to platform
(±SEM). There were no significant differences between groups during retraining.
Microinfusion of WIN 55,212-2 into the parietal cortex did not impact memory
consolidation or influence memory retention.
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IEG mRNA levels- dentate gyrus microinfusion
The effects of WIN 55,212-2 on IEG (Arc, cFos, zif268) activity following MWT
training are shown in Figure 20. Repeated measures ANOVAs were conducted on IEG
mRNA levels with IEG (Arc, cFos, zif268), Region (dentate gyrus, parietal cortex) and
Drug (vehicle, WIN 55,212-2) as within-subjects factors. Control conditions (Swim only,
Drug only) were compared to combination conditions (Drug + MWT training). Within
the dentate gyrus, there were no significant main effects of Drug for any of the IEGs of
interest (Arc, cFos, zif268), ps > 0.238. RT-PCR analysis revealed vehicle and WIN
55,212-2 mRNA levels were not significantly different on average. However, there were
other significant interactions and main effects reported below which are divided by gene
of interest.
For the IEG Arc there was a significant main effect of Region [F(1,17) = 8.371,
ηp2 = 0.330] indicating IEG Arc mRNA average values were higher in the dentate gyrus
than in the parietal cortex [MDG= 5.768, MPC= 1.277], Figure 20 A&D. There was a
significant main effect of Condition [F(2,17) = 3.934, ηp2 = 0.316] indicating the average
Arc mRNA value were different between MWT only, Drug only, and MWT+Drug
conditions. Simple contrasts revealed that MWT+Drug was significantly higher than
MWT only [MMWT = 0.494, MMWT+DRUG = 5.416]. Within the dentate gyrus, the
significant main effect of Condition approached significance [F(2,17) = 3.373, p = 0.058,
ηp2 = 0.284] indicating the average Arc mRNA values were different between MWT
only, Drug only, and MWT+Drug conditions. Simple contrasts revealed that Drug Only
and MWT+Drug were both significantly higher than MWT only. Within the dentate
gyrus MWT+Drug condition, the Drug difference showed a trend towards significance
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[F(1,7) = 3.776, p = 0.093, ηp2 = 0.350; MVEH = 7.47, MWIN = 10.7983], WIN 55,212-2
rats showed slightly elevated Arc mRNA expression. No other interactions or main
effects were significant, ps > 0.092.
For the IEG cFos there was a significant main effect of Region [F(1,17) = 8.063,
ηp2 = 0.322] indicating IEG cFos mRNA average values were higher in the parietal
cortex compared to the dentate gyrus [MDG = 1.584, MPC = 2.691]. The main effect of
Condition approached significance [F(2,17) = 3.009, p = 0.076, ηp2 = 0.261] indicating
the average cFos values were different between MWT only, Drug only, and MWT+Drug
conditions. Simple contrasts revealed that MWT+Drug was significantly higher than
MWT only [MMWT = 1.047, MMWT+DRUG = 2.662]. Within the dentate gyrus, the main
effect of Condition was significant [F(2,17) = 6.624, ηp2 = 0.438] indicating the average
cFos mRNA value were different between MWT only, Drug only, and MWT+Drug
conditions. Simple contrasts revealed that Drug Only and MWT+Drug were both
significantly higher than MWT only. Within the dentate gyrus MWT+Drug condition, the
Drug difference showed a trend towards signficance [F(1,7) = 3.721, p = 0.095, ηp2 =
0.347, MVEH = 1.713, MWIN = 2.6818], WIN 55,212-2 rats showed slightly elevated cFos
mRNA expression. No other interactions or main effects were significant, ps > 0.237.
For the IEG zif268 there was a significant interaction between Region X
Condition [F(2,17) = 4.526, ηp2 = 0.347]. Simple contrasts revealed that IEG zif268
mRNA values were higher in the parietal cortex for MWT only, Drug Only, and MWT&
Drug Conditions compared to the dentate gyrus. There was also a significant main effect
of Region [F(1,17) = 97.613, ηp2 = 0.852] indicating IEG zif268 mRNA average values
in the parietal cortex were higher than the dentate gyrus [MDG = 1.613, MPC = 3.375]. The
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main effect of Condition approached significance [F(2,17) = 3.038, p = 0.074, ηp2 =
0.263] indicating the average zif268 value was different between MWT only, Drug only,
and MWT+Drug conditions. No other interactions or main effects were significant, ps >
0.249.
IEG mRNA levels- parietal cortex microinfusion
The effects of WIN 55,212-2 on IEG (cFos, Arc, zif268) activity following MWT
training are shown in Figure 20. Repeated measures ANOVAs were conducted on IEG
mRNA levels with IEG (cFos, Arc, zif268), Region (dentate gyrus, parietal cortex) and
Drug (vehicle, WIN 55,212-2) as within-subjects factors. Control conditions (Swim only,
Drug only) were compared to combination conditions (Drug + MWT training). Within
the parietal cortex, there were no significant differences between drug conditions for any
of the IEGs of interest (Arc, cFos, zif268), ps > 0.177.
For the IEG Arc there was a significant interaction between Region X Condition
[F(2,12) = 6.638, ηp2 = 0.525] indicating IEG Arc mRNA average values were higher in
the parietal cortex over the dentate gyrus for MWT only and MWT + Drug conditions,
but not Drug only. There was a significant main effect of Condition [F(2,12) = 13.519,
ηp2 = 0.693] indicating the average Arc mRNA values were different between MWT
only, Drug only, and MWT+Drug conditions.

Simple contrasts revealed that

MWT+Drug was significantly higher than MWT only. Within the dentate gyrus, the
main effect of Condition approached significance [F(2,12) = 3.182, p = 0.078, ηp2 =
0.347] indicating the average Arc mRNA values were different between MWT only,
Drug only, and MWT+Drug conditions. Pairwise comparisons revealed that Drug Only
was significantly higher than MWT only.
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For the IEG cFos the main effect of Condition was significant [F(2,12) = 3.852,
ηp2 = 0.391] indicating the average cFos values, were different between MWT only, Drug
only, and MWT+Drug conditions. Simple contrasts revealed that Drug only was
significantly higher than MWT only [MMWT = 1.047, MDRUG = 2.703]. No other
interactions or main effects were significant, ps > 0.214.
For the IEG zif268 there was a significant main effect of Region [F(1,12) =
15.010, ηp2 = 0.556] indicating IEG zif268 mRNA average values in the parietal cortex
were higher than the dentate gyrus [MDG = 1.810, MPC = 3.259]. The main effect of
Condition was significant [F(2,12) = 3.852, ηp2 = 0.410] indicating the average zif268
values were different between MWT only, Drug only, and MWT+Drug conditions.
Simple contrasts revealed that MWT Only was significantly elevated compared to Drug
only. No other interactions or main effects were significant, ps > 0.221.
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Figure 20: Immediate early gene mRNA expression following MWT training. Effect
of WIN 55,212-2 on IEG (Arc, cFos, zif268) mRNA levels in the dentate gyrus (A-C)
and parietal cortex (D-F). Data represent group mean (+SEM). There were no significant
differences in Arc (A, D), cFos (B, E), or zif268 (C, F) expression between drug groups.
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Discussion
It was hypothesized that the cannabinoid agonist WIN 55,212-2 infused into the
dentate gyrus would result in a consolidation deficit in the MWT, however, this did not
occur. The present study found that a single dose of vehicle and WIN 55,212-2 were
indistinguishable on resulting MWT behavioral retention tests. Moreover, search
performance during the probe for WIN 55,212-2 rats was more precise in average search
distance from previous platform location. Conversely, during the first trial of retraining,
the WIN 55,212-2 rats were slightly impaired compared to vehicle controls. These
findings together may indicate search persistence is impacted in WIN 55,212-2 rats, and
that their precise search strategy during the no-platform probe resulted in diminished
search during the first trial of retraining. This may be partially explained by WIN 55,2122 facilitating reversal learning (Pamplona, et al., 2006). Interestingly, the present study
found that the cannabinoid antagonist + cannabinoid agonist condition did significantly
impair search performance during the memory probe. The AM 251+WIN 55,212-2 rats
had longer latencies and path length to the previous platform location. However, no
significant drug differences were evident during the first trial of retraining. When vehicle
or WIN 55,212-2 was infused into the parietal cortex, there was no difference between
groups in memory retention; therefore, the parietal cortex is not critically important to
memory consolidation in the MWT.

Together, these results did not parallel previous

findings found with systemic injections and are unable to provide dentate gyrus regional
specificity for cannabinoid induce MWT consolidation deficits, although FCM
verification confirmed proper cannula placement in microinfusion site. It is likely that
other regions of the hippocampal formation in combination, or CA1 in combination with

	
  

72	
  

	
  
	
  

dentate gyrus, contribute to cannabinoid induced memory impairment. Further, it may be
that spatial memory consolidation requires multiple brain regions simultaneously, i.e.
integration between the frontal cortex, and hippocampus to be stored properly.
In terms of the impact the cannabinoid agonist had on immediate early gene
expression in the dentate gyrus and parietal cortex, it was expected that WIN 55,212-2
would reduce overall IEG expression compared to controls, however, this did not occur.
The present study found no differences in Arc, cFos, and zif268 IEG expression between
vehicle and WIN 55,212-2 conditions. There were significant differences between swim
only, drug only, and combination swim+drug conditions, with swim only resulting in the
lowest Arc, cFos, zif268 IEG expression. Low immediate early gene expression resulting
from MWT swimming behavior is consistent with drug only controls showing similar
expression to swim+drug conditions (i.e. swimming provided little elevation in
expression). This also indicates the vehicle solution can result in significant IEG
expression by itself. Trends in the date indicate WIN 55,212-2 elevated Arc and cFos
expression in the dentate gyrus following dentate gyrus microinfusion, but would need
more data to be conclusive. Although the results are not in line with expectations, there is
no surprise. The signaling pathways evoked by cannabinoid administration are complex
and poorly understood. Although cFos, zif268, and Arc expression appear to be important
for LTP, their specific role in memory consolidation and behavior remains unclear.
In term of addressing regional specificity, the present findings show that the
dentate gyrus alone is not the region responsible cannabinoid-induced memory
consolidation deficits. An alternative explanation may be the dentate gyrus is not
critically involved in short-term memory consolidation. Yim et al. (2008) showed that
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WIN 55,212-2 infused into the dorsal hippocampus impaired long-term/one-month
consolidation processes, with no impact on short-term consolidation processes. Although
the MWT training procedures were different between Yim et al. (2008) and the present
study, perhaps a memory retention evaluation at 24 hours is too soon to detect a
consolidation deficit. It is unknown if a consolidation deficit in the present study would
occur if memory retention was performed at the two-week or one-month time frame.
Conversely, we were previously able to reliably detect a consolidation difference at 24
hours using systemic i.p. injections several times (Candelaria-Cook, 2009; CandelariaCook & Hamilton, 2008, 2010); therefore, the lack of consolidation deficits in the present
study is likely more related to insufficient regional inactivation.
The role of the dentate gyrus in spatial memory consolidation can be debated.
Previous research by Okada & Okaichi (2009) has shown that the hippocampus is a
functional unit for spatial memory and a certain degree of cooperation between
subregions is necessary for proper memory storage. Further, lesions to the dentate gyrus,
CA3, and CA1 cause varying degrees of impairment in MWT acquisition depending on if
the hippocampal commissure was also severed. This indicates that the associationalcommissural pathway is critical to maintaining proper spatial memory consolidation as it
relays spatial information between subregions on unilateral and contralateral sides. The
complexity and redundancy present in hippocampal networks is resilient enough to
endure partial subregion deactivations and lesions without impaired spatial memory.
It is also necessary to consider what memory phase was being studied. Posttraining drug infusion and consolidation require different hippocampal subregions than
acquisition. For MWT acquisition, rats can still learn the task with as little as a quarter of
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the dorsal hippocampus intact (Moser, Moser, Forrest, Andersen, & Morris, 1995).
However, two-thirds of the dorsal hippocampus is necessary for memory retrieval, when
tested with lesions and muscimol temporary inactivation (Moser & Moser, 1998a,
1998b).
Not detecting a significant difference in immediate early gene expression between
drug groups following MWT training and drug infusion may not be too surprising.
Previous research has shown that the expression of the IEGs zif268 and cFos in
hippocampal subregions following training in the MWT is not a direct predictor of
explicit spatial location learning (Guzowski, et al., 2001). Also, it is important to have
proper control conditions due because immediate early genes are activated by an array of
behavior, learning, and experiences. Previously, Shires and Aggleton (2008) looked at
IEG correlates of hippocampal-dependent learning in the MWT and concluded that
problems in interpretation may arise due to the nature of the control conditions. They
found a significant difference between cage controls, which were the baseline minimum
in IEG expression, compared to free-swimming controls.
A few limitations of the present study should be taken into consideration. The
present study was limited to the analysis of males. Future work should address if sex
differences exist in spatial behavior following cannabinoid administration. The present
study was also limited to one WIN 55,212-2 and AM 251 drug dose. A high dose was
selected based on previous literature on cannabinoid-induced deficits on spatial memory.
The results obtained here with a high dose of cannabinoids were subtle, but future doses
ranging from low to high should be investigated, in case low doses produce a different
result. Considering the unexpected nature of the AM 251 finding, the drug dosing may
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need to be modified or the timing between infusions changed. Future research should
also use an antagonist only condition in addition to the antagonist + agonist condition
used here. This would help in determining if the AM 251 dose was too high in the
current study. Also, given the uncertainty of drug distribution within the dentate gyrus, it
may be useful to use a fluorescent cannabinoid agonist in the future to map the degree of
diffusion. It may be that the amount of cannabinoid agonist infused was too little to
completely inactivate the entire dorsal dentate gyrus, and the amount of dentate spared
was enough to successfully aide in memory consolidation.
Additional limitations of the present study’s IEG expression should also be taken
into consideration. Here, IEG expression was compared in two areas (dentate gyrus and
parietal cortex), given that immediate early genes expression is complex and varies
between regions; there may be complementary changes elsewhere in the brain. Even
though the present study included a modest set of control measures for IEG expression,
more controls should be investigated in the future (i.e. cage controls with no behavior or
drug administration). Although, swim only behavior was correlated with slight changes
in gene expression, it may be important to control the amount time of spent swimming
during MWT training prior to drug infusion with yoked swim controls. Furthermore,
given the design of the present study, the rats of this study had abundant MWT
experience; in the future it may be useful to use rats with novel experience in the MWT
task prior to analyzing IEG expression. Perhaps changes in IEG expression are higher
with task novelty and new learning experiences. Lastly, the current study microdissected
the entire dentate gyrus with dorsal and ventral aspects, but the drug was only infused
into the dorsal dentate. Perhaps using only the dorsal dentate, with tissue punch
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techniques, would reveal differences in IEG expression more precisely. Alternatively,
fluorescent in situ hybridization would reveal IEG expression within granule cells. These
techniques were not further explored in the current study given the lack of group
differences found.
In summary, the present findings demonstrated that the dentate gyrus and its
activity related immediate early gene expression were not altered by a cannabinoid
agonist microinfusion following MWT training. Conversely, the combined cannabinoid
antagonist + agonist microinfusion following MWT training did impair 24-hour
consolidation. These findings imply that cannabinoid activity within the dentate gyrus is
essential but not required for proper memory consolidation. It is likely that other regions
of the hippocampal formation in combination, or CA1 individually, contribute to
cannabinoid induced memory impairment.

Further, it may be that spatial memory

consolidation requires multiple brain regions simultaneously, i.e. integration between the
frontal cortex and hippocampus to be stored properly.
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CHAPTER 5: DENTATE GYRUS ELECTROPHYSIOLOGY
In order to further investigate the influence cannabinoids have on memory
consolidation in the dentate gyrus, we now turn to cellular forms of memory and synaptic
plasticity present in the well-defined dentate gyrus circuitry, specifically two projections
from the entorhinal cortex which terminate in the dentate gyrus, the medial perforant path
and lateral perforant path. The following chapter discusses the effects the cannabinoid
agonist WIN 55,212-2 has on long-term potentiation (LTP), paired-pulse facilitation
(PPF), and specific aspects of functional activity such as neurotransmitter release and
immediate early gene (IEG) signaling pathways, which may underlie memory
consolidation processes in the dentate gyrus. A brief introduction to each technique can
be found below.
Long-term potentiation is usually discussed as the analog to cellular memory and
refers to a persistent increase in synaptic strength that is produced by brief highfrequency stimulation at excitatory afferents (Andersen, Eccles, & Loyning, 1964; Lomo,
1971). Within in the dentate gyrus, when the perforant path is stimulated a positive
fEPSP is recorded which is reflective of the depolarization of a granule cell population
(Lomo, 1971). Another response to stimulation of the perforant path is the population
spike, which reflects the number and synchrony of the granule cell population (Andersen,
Bliss, & Skrede, 1971).

In dentate gyrus medial perforant path and mossy fiber

projections, LTP is considered NMDA-dependent (Harris & Cotman, 1986). CB1
receptor activation can acutely block the induction of LTP via the inhibition of
presynaptic glutamate release (Shen, et al., 1996; Sullivan, 2000), which would prevent
sufficient postsynaptic depolarization required to elevate calcium levels.
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Paired-pulse facilitation is a form of short-term plasticity that is indicative of
changes in neurotransmitter release probability and can be used in various stimulation
protocols to reveal differences in GABA and glutamate release from dentate granule cells
(Andersen, et al., 1971; Andersen, et al., 1964; Lomo, 1971; Sloviter, 1991). PPF is
studied by giving a pair of pulses to the synaptic pathway and comparing the amplitude
of the second response with that of the first response. PPF is related to a nonlinear
calcium dependence of vesicular release and the ability of residual calcium to markedly
augment the effectiveness of successfully timed stimuli. It should be noted that the
amount of PPF depends on the interval between the two pulses; PPF decreases as the
interval between stimuli increases. The formula to calculate the PPF is: (PPR= PSC #2/
PSC #1). It is generally accepted that a reduction in PPR ratio is equivalent to facilitation
of neurotransmitter release. When the second response is enhanced it represents reduced
neurotransmitter release with the first pulse. The phenomenon of PPR reduction being
equivalent to paired pulse facilitation is explained by the fact that sufficient
neurotransmitter release occurred during the first stimulus, which thereby rendered the
second stimulus smaller.
The PPR can also be used as a measure of feedback and feedforward inhibition in
the dentate gyrus. At inter-pulse intervals of 40 ms or less, a decrease in the second
population spike is due to recurrent/feedforward inhibition, a process by which granule
cell stimulation triggers basket cell inhibition of other granule cells via the perforant path
(Ribak & Seress, 1983; Sloviter, 1991), Figure 21. However, at inter-pulse intervals
greater than 40 ms an increase in the second pop-spike occurs due to recurrent excitatory
synapses (Johnston & Amaral, 2004).
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Figure 21: Dentate gyrus feedforward and feedback inhibition. Feedforward
inhibition is a process by which granule cell stimulation triggers basket cell inhibition of
other granule cells via the perforant path. Feedback inhibition is a process by which
granule cell stimulation triggers basket cell inhibition of other granule cells and mossy
cell excitation via mossy fibers. Abbreviations: LPP, lateral perforant path; MPP, medial
perforant path; A-CP, associational-commissural projection
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Cannabinoid agonist WIN 55,212-2 alters dentate gyrus perforant path paired-pulse
facilitation and long-term potentiation in vivo.
Abstract
Endogenous cannabinoids are fundamental retrograde messengers involved in the
rapid modulation of synaptic transmission. The present study evaluated the effects of
WIN 55,212-2, a potent cannabinoid agonist, on dentate gyrus paired pulse facilitation
and long-term potentiation in vivo. WIN 55,212-2 (10 µg/µL) or vehicle was unilaterally
infused into the right dorsal hippocampus prior to commencing perforant path to dentate
gyrus electrophysiology recordings.

Upon completion of physiology brains were

processed for immediate early gene expression. The data suggest WIN 55,212-2 blunted
the magnitude of baseline population spike amplitude at current intensities between 500600 µA, without changing baseline fEPSP response. The cannabinoid agonist also altered
fEPSP PPRs indicating WIN 55,212-2 decreased the probability of glutamate release and
changed GABA mediated inhibition. WIN 55,212-2 also significantly increased fEPSP
amplitude following perforant path to dentate gyrus high frequency stimulation. And
lastly, WIN 55,212-2 rats had significantly higher Arc expression in the stimulated
dentate gyrus compared to vehicle rats. WIN 55,212-2 may modulate LTP through a
combined reduction of glutamate, and GABA via feedforward and feedback processes.
WIN 55,212-2 may disturb baseline and activity-dependent changes via different
mechanisms in different inhibitory circuits. When taken together, these results suggest
cannabinoids selectively alter medial perforant path projection. However, the reduced
baseline granule cell population spike amplitude and altered GABA mediated feedback
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inhibition may be an important factors underlying cannabinoid induced memory
impairments.
Introduction
Endocannabinoids are involved in the rapid modulation of synaptic transmission
in the CNS by retrograde signaling causing local inhibitory effects on both excitatory and
inhibitory neurotransmitter release that persists for minutes to hours. CB1 receptors are
found on both GABAergic and glutamatergic nerve terminals and may inhibit either of
those two neurotransmitters. In the hippocampus and neocortex, CB1 receptors are
expressed by a defined subpopulation of GABAergic interneurons (Katona, et al., 1999),
as well as by hippocampal glutamatergic neurons (Katona, et al., 2006) where they act as
glutamate release inhibitors. Mossy cells of the dentate hilus contain the highest levels of
CB1 receptors amongst excitatory hippocampal neurons (Kawamura, et al., 2006;
Monory, et al., 2006). Within the dentate gyrus, CB1 receptors alter the release of
glutamate from mossy cells and GABA from basket cells. The critical location of
cannabinoid receptors have the potential to disrupting synaptic signaling and impair
feedforward and feedback inhibition, creating long-term memory impairments.
Paired pulse facilitation (PPF) is a form of short-term plasticity that is indicative
of changes in neurotransmitter release probability and can be used to assess differences in
GABA and glutamate release (Ribak & Seress, 1983; Sloviter, 1991). Previous studies
examining cannabinoids and PPF ratios suggest a presynaptic or retrograde mechanism is
indicated if an increased PPF ratio exists. This is based on prior research showing that
postsynaptic generated endocannabinoids and CB1 receptor activation are correlated with
increased PPF ratios (Gerdeman, et al., 2002). PPF ratios can also be used through two
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difference stimulation protocols to indicate probability of glutamate release in the dentate
gyrus and GABAergic inhibition of dentate granule cells. It may be that in the dentate
gyrus cannabinoids selectively alter the release of glutamate inhibiting maintenance of
Long-term potentiation (LTP) and memory consolidation.
LTP is a more persistent form of long-term synaptic plasticity than PPF.
Cannabinoids have been shown to impair LTP (Collins, et al., 1995; Hill, et al., 2004;
Nowicky, et al., 1987; Terranova, et al., 1995) thereby impacting long lasting synaptic
plasticity in a significant manner. It may be the case that the reduction in LTP is due to
reduced glutamate transmission following CB1 receptor activation (Shen, et al., 1996;
Sullivan, 2000). By inhibiting glutamatergic responses, cannabinoids may be indirectly
impacting normal LTP, and possibly changing gene expression underlying the neural
mechanisms of long term memory storage.
Within the ipsilateral associational-commissural projection, a feedback loop is
created to regulate dentate gyrus responsiveness between excitatory mossy cells axons
onto granule cells (Johnston & Amaral, 2004; Laurberg & Sorensen, 1981).
Endocannabinoids have been known to adjust network activity in the dentate gyrus
following excitation by retrograde signaling from granule cell spines onto CB1 receptor
containing mossy cells (Uchigashima, et al., 2011). Within the associational-commissural
afferents may also be where exogenous cannabinoids are most disruptive by creating
feedback inhibition disruption. If cannabinoids inhibit mossy cell excitation of proximal
granule cell dendrites following feedback inhibition, the end result may be reduced
excitation of the granule cell, reduced synaptic plasticity, and reduced hippocampaldependent learning and memory.
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The medial perforant path is involved in long-term potentiation following high
frequency stimulation of entorhinal inputs. It has been shown that during high frequency
stimulation of the medial perforant path in vivo, CB1 activation increases glutamate
release from perforant path synapses while inhibiting release of GABA from local
interneurons (Sokal, Bennetti, et al., 2008). Additionally it has been shown that medial
perforant path stimulation preferentially recruits inhibitory basket cells in a feedforward
fashion, bypassing excitatory granule cell inputs and feedback inhibition (Ewell & Jones,
2010).
Following induction of LTP in the dentate gyrus, immediate early genes (IEGs)
rapidly respond to the cellular stimulus. Three IEGs in particular are of interest to
memory consolidation researchers: Arc (Activity-dependent cytoskeleton associated
protein), cFos, and zif268 which all show elevation following perforant path LTP. Arc
plays a critical role in regulating translational machinery during LTP consolidation
(Bramham, Worley, Moore, & Guzowski, 2008). Induction of LTP in the dentate gyrus is
associated with a rapid increase in Arc up to two hours following high-frequency
stimulation (Abraham et al., 1993). The Arc protein exists in high quantities on
hippocampal dendrites (Lyford et al., 1995), and Arc mRNA accumulates rapidly
following recent dendritic synaptic activity (Steward, Wallace, Lyford, & Worley, 1998).
Disruption of Arc protein expression impairs LTP maintenance and consolidation,
without impacting LTP induction (Guzowski, et al., 2000). The IEG zif268 also rapidly
increases following high frequency stimulation for up to two hours (Abraham, et al.,
1993; Richardson et al., 1992). In fact, in zif268 knockouts late LTP is absent suggesting
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zif268 is essential for transitioning from short-term to long-term synaptic plasticity
(Jones, et al., 2001).
The present study was designed to examine the impact of a potent cannabinoid
agonist (WIN 55,212-2) on synaptic plasticity and resulting immediate early gene
expression within the hippocampal dentate gyrus. In adult rats, a high-dose of WIN
55,212-2 or vehicle was delivered directly into the upper blade of the dentate gyrus
preceding unilateral stimulation of the perforant path to dentate gyrus circuit. To observe
differences in glutamate and GABA transmission paired pulse ratios were examined
along with LTP to evaluate changes in synaptic plasticity. Immediate early gene (Arc,
cFos, and zif268) mRNA levels were measured in the dentate gyrus after physiological
recordings were completed. Together these manipulations should reveal if a cannabinoid
agonist produces changes in synaptic plasticity in the dentate gyrus, changes in
neurotransmission and changes to immediate early gene levels.

By changing

neurotransmitter release and signal transduction pathways CB1 receptors may be critically
involved in dampening neuronal signals to foster forgetting naturally in the body.
Experimental procedures
Animals
Subjects were 16 male Long-Evans rats acquired from Harlan Laboratories
(Indianapolis, IN). All rats were three months of age at the beginning of the experiments.
Rats were pair-housed in standard clear plastic cages and maintained in a temperature and
humidity controlled vivarium with food and water available ad libitum. The University
of New Mexico Institutional Animal Care and Use Committee (IACUC) approved all
experimental procedures.
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Drug treatments
All drug doses and vehicle preparations were selected according to previous
literature (Lichtman, et al., 1995; Yim, et al., 2008). WIN 55,212-2 (Sigma-Aldrich) was
prepared for microinfusion at a high dose concentration of 10 µg/µL in vehicle solution.
The vehicle solution consisted of a 1:1:18 ratio ethanol:alkamuls:saline, respectively.
WIN 55,212-2 was first dissolved and vortex in a 1:1 mixture of ethanol and alkamuls
EL-620 (kindly provided by Rhodia Pharma Solutions). The mixture brought to volume
with 18 parts sterile Dulbecco’s phosphate buffered saline (Sigma-Aldrich), vortex and
sonicated. Both drug and vehicle solutions were prepared fresh daily.
Microinfusions
Rats were divided into two experimental groups (n = 8): vehicle control and WIN
55,212-2.

Drug microinfusions occurred after rats were deeply anesthetized with

urethane and positioned in the stereotaxic frame in the initial stages of surgery before
electrodes were lowered into recording position.

WIN 55,212-2 or vehicle was

unilaterally infused into the right dorsal hippocampus with a Hamilton Neuros 1.0 µL 32
gauge syringe (Hamilton Company) attached to a stereotaxic arm on the stereotaxic frame
(David Kopf Instruments).

The syringe tip coordinates were -0.02 mm above the

perforant path recording site (AP: -3.5; ML: -2.2; DV: -3.3 in millimeters relative to the
skull surface at Bregma). The rate of infusion was 0.5 µL/min for one minute. The
syringe was left in place for an additional two minutes to allow for drug diffusion. The
extent of diffusion was estimated to be one mm in diameter from the injector tips (see
Chapter 4 fluorescent microscopy).
In-vivo electrophysiology
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Rats were deeply anesthetized with urethane at a dose (1.35 g/kg) dissolved in a
concentration of 250 mg/mL (two injections of 0.75 g/kg, 30 min apart).

Rectal

temperature was monitored and maintained at 37 °C. Once animals were non-responsive
to a hind-limb pinch they were placed into a stereotaxic frame (David Kopf Instruments).
The stereotaxic procedure was conducted as previously described by Sutherland et al.,
(1997). After cleaning the scalp, a midline incision was made to expose the skull. Five
holes were drilled using a dental burr for positioning circuit components. Five stainless
steel self-tapping screws (Small Parts Inc.) attached to gold Amphenol pins (Allied
Electronics) were inserted into the skull; two served as reference and ground components
of the differential recording circuit, one served as a return component for the stimulating
circuit, and two provided additional structural support. Bregma was carefully measured
with the drill bit and two additional holes were drilled for electrode placement. Rats were
surgically implanted with one recording electrode and one stimulating electrode
composed of Teflon- coated stainless steel wires (114 µm outer diameter; A-M Systems).
The recording electrode was placed unilaterally in the right hemisphere into the hilar
region of the dentate gyrus at the following coordinates relative to Bregma: AP -3.5 mm,
ML -1.8 mm, DV -3.5 mm (Paxinos & Watson, 2005). The stimulating electrode was
placed unilaterally in the right hemisphere into the medial perforant path at the following
coordinates relative to Bregma: AP -8.1 mm, ML -4.3, DV -4.0 mm (Paxinos & Watson,
2005). Electrodes were connected to an isolated pulse stimulator (Model 2100; A-M
Systems) and differential AC amplifier (Model 1800; A-M Systems). Recording signals
were amplified (1000X) and converted to digital (Models PCI 6221 and BNC- 2090;
National Instruments) then transferred to a personal computer for monitoring and
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recording of the dentate gyrus evoked potential. Final electrode depths were optimized,
varying recording and stimulating depth, until ideal placement for stimulation of the
medial perforant path occurred under electrophysiological guidance. Optimal electrode
placement was evident by a positive excitatory postsynaptic potential (EPSP) with a
superimposed maximal negative population spike evoked by test pulses at amplitude of
400 µA (100 µs pulse duration, 10 s inter-pulse interval). Rats failing to exhibit a
population spike (PS) were discarded from the study.
Baseline input/output curve
Following optimal placement of electrodes an input/output curve was generated
using 100 µA, 300 µA, 500 µA, and 600 µA pulse amplitude intensities. Each amplitude
was repeated five times with a 30 s inter-pulse interval. The I/O curve data was
transferred to a Macbook where a Matlab program calculated the average evoked
response at each pulse amplitude intensity, 40% fEPSP, 40% PS, and 1% PS values. The
amplitude of the fEPSP was calculated at the initial slope midpoint at a time point after
the stimulus artifact. The amplitude of the PS was calculated using the tangent method,
defined as the voltage difference between a tangent to the two positive peaks and the
trough of the negative peak. The PS latency was the time between the stimulation and the
population spike.
Paired pulse facilitation
Following I/O curve generation, paired pulse facilitation was measured with two
protocols. First, paired pulse submaximal ratios were obtained. Following a previous
protocol (Varaschin, 2012) the fEPSP was measured without a population spike present
to measure the probability of glutamate release.
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intensity used was 90% of baseline current needed to evoke a population spike (90% of
Matlab 1% PS calculation). The paired pulse submaximal ratios were obtained at interpulse intervals of 30, 40, and 80 milliseconds (five pulses, 100 µs duration, 30 s interpulse interval). The PPR was calculated by dividing the fEPSP slope from the second
pulse by that of the first pulse.
Next, paired pulse near-maximal ratios were obtained. Following a previous
protocol (Varaschin, 2012) the population spike was maximized to assess GABAergic
inhibition of dentate granule cells. The stimulating current used for all animals was 600
µA. The paired pulse near-maximal ratios were obtained at inter-pulse intervals of 10, 20,
30, 40, 60, 80, 100, 200, 400, 600, and 1000 milliseconds (five pulses, 100 µs duration,
30 s inter-pulse interval). The PPR was calculated by dividing the fEPSP slope or
population spike magnitude from the second pulse by that of the first pulse.
Long-term potentiation
Immediately following the PPF protocols, the LTP protocol began. A pulse
amplitude stimulus intensity of 40% maximum population spike (ES40), roughly 300-400
µA, was used for baseline, high frequency stimulation (HFS), and post-HFS recordings.
Baseline (pretetanus) responses were recorded to single pulses with a 30 s inter-pulse
interval over 10 minutes. LTP was induced by three trains of 10 pulses of HFS at 400 Hz
with 30 s inter-train intervals. After tetanus, post-HFS evoked responses were measured
to single pulses with a 30 s inter-pulse interval over 60 minutes. Baseline (pretetanus)
responses were compared to the post-tetanus data. The fractional change in fEPSP slope,
PS amplitude, and PS latency were compared between vehicle and WIN 55,212-2
conditions. Fractional change was calculated by subtracting the second response
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amplitude from the first response amplitude then dividing by the first response amplitude.
The data was further sampled into bin sizes of one minute in length to minimize random
fluctuations. The post-tetanic potentiation phase (immediately four to five minutes post
HFS) was also measured separately from LTP.
Immediate early gene expression
After post-HFS recordings were completed, the rat was euthanized. The brain
was quickly extracted, and placed in ice-cold PBS. The brain was quickly extracted, and
placed in ice-cold phosphate buffered saline. The brains were visually inspected for
proper cannula placements and the dentate gyrus and parietal cortex were microdissected,
placed in RNA free tubes, and stored at -80 °C. Quantitative real-time polymerase chain
reaction (qRT-PCR) was performed according to a previous protocol (Caldwell, et al.,
2008) and Arc, cFos, zif268 mRNA levels were measured using primers designed by Dr.
Clark Bird. Primers were designed from national database sequences of rat reference
mRNA and validated with NCBI primer BLAST software. First, mRNA was extracted
from the stored tissue using a RNeasy mini kit (Qiagen) and mRNA concentration was
determined using a NanoDrop spectrophotometer (NanoDrop Technologies). cDNAs
were created using 1 µg total mRNA and Superscript II Reverse Transcriptase (Invitrogen
Corporation) following manufacturer’s protocol and stored at -20 °C until used. qRTPCR reactions were performed on an Applied Biosystems 7100 Real Time PCR System
using 96-well plates (Applied Biosystems). Gene expression levels were analyzed using
SYBR Green (Life Technologies) detection in triplicate reactions against GAPDH values.
Based on dissociation curves, abnormal samples were discarded. Relative levels of IEG
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(Arc, cFos, and zif268) expression compared to control GAPDH expression were
calculated using the 2-

ΔΔ

Ct

method described by (Livak & Schmittgen, 2001).

Results
Analyses of Variance (ANOVAs) were performed using SPSS (version 22 for
Macintosh). All test statistics reported here were significant at p < 0.05 unless otherwise
noted. For all analyses Drug condition (vehicle, WIN 55,212-2) was a between-subjects
factor. I/O analysis was generated on the complete data set of 16 brains (7 vehicle, 9
WIN 55,212-2). Due to recording difficulties (i.e. PPF software coding issues) and
incomplete data sets (i.e. premature urethane overdose), animal numbers varied for paired
pulse recordings and LTP recordings. All rats included in the analyses had a measured
population spike greater than 2 mv at 600 µA current intensity. For paired pulse analyses
a total of 14 brains were included (5 vehicle, 9 WIN 55,212-2) due to difficulties with the
PPF recording software with two vehicle rats. For LTP analysis a total of 14 brains were
included in analysis (6 vehicle, 8 WIN 55,212-2) due to one vehicle premature death and
one WIN 55,212-2 recording difficulty. Separate ANOVAs were conducted for various
experimental components: I/O curve, PPR, LTP, IEG. Effect sizes (partial eta squared;
ηp2 ) are reported for all effects.
Input/output
The effects of WIN 55,212-2 on baseline perforant path stimulation and dentate
gyrus evoked potential at 100 µA, 300 µA, 500 µA, and 600 µA current intensities are
shown in Figure 22. Repeated measures ANOVAs were conducted on fEPSP and PS
amplitude with the four current intensities as within-subjects factors.

There was a

significant main effect of Current in both fEPSP response [F(3,42) = 44.375, ηp2 = 0.756]
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and PS amplitude [F(3,42) = 30.739, ηp2 = 0.687]. Follow-up contrasts revealed
significant linear trends in fEPSP response [F(1,14) = 47.837, ηp2 = 0.774] and PS
amplitude [F(1,14 )= 35.296, ηp2 = 0.716] indicating higher current intensities resulted in
higher evoked responses. The fEPSP slope and PS amplitude increased proportionally to
larger current intensities (Figure 22C).
There was a significant Current X Drug interaction in PS amplitude [F(3,42) =
3.892, ηp2 = 0.218]. Based on visual inspection of Figure 22B showing large mean
differences in PS amplitude at 500 µA [MVeh = 5.464, MWIN = 2.166] and 600 µA [MVeh =
6.929, MWIN = 3.620] follow-up pairwise comparisons were conducted. WIN 55,212-2
rats had a significantly reduced PS amplitude compared to vehicle rats at the 500 µA
current intensity [F(1,14) = 4.985, ηp2 = 0.263], and a difference approaching significant
at the 600 µA current intensity [F(1,14) = 3.645, p = 0.077, ηp2 = 0.207]. The main effect
of Drug approached significance in PS amplitude [F(1,14) = 3.953, p = 0.067, ηp2 =
0.220] indicating WIN 55,212-2 rats had reduced overall PS amplitude compared to
vehicle rats [MVeh = 3.326, MWIN = 1.563].

No other effects or interactions were

significant for fEPSP [all ps > 0.450].
It was determined there were no overall differences between vehicle and WIN
55,212-2 I/O evoked fEPSP responses. However, it was clear that WIN 55,212-2
administration impacted I/O evoked PS amplitude at higher current intensities primarily
500 µA, but also possibly at 600 µA. Given these I/O findings it is possible WIN 55,2122 administration changed granule cell responsiveness.
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Figure 22: Baseline granule cell responsiveness. Effect of WIN 55,212-2 on fEPSP (A)
and PS amplitude (B) in the dentate gyrus at four perforant path stimulus intensities, with
representative traces for each group (C). Data represent group mean ± SEM. WIN
55,212-2 rats had significantly lower PS amplitude at 500 µA current intensity (* denotes
p < 0.05), and a difference approaching significance at 600 µA († denotes p = 0.077). No
statistically significant fEPSP differences were found between groups.
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Paired pulse ratios at sub-maximal stimulation levels
The effects of WIN 55,212-2 on dentate gyrus paired pulse ratios at sub-maximal
stimulation levels at 30 ms, 40 ms, 80 ms inter-pulse intervals are shown in Figure 23.
Repeated measures ANOVAs were conducted on fEPSP PPRs with the three inter-pulse
intervals as within-subjects factors. There was a significant main effect of Inter-pulse
Interval on fEPSP PPR [F(2,22) = 6.235, ηp2 = 0.362]. Follow-up contrasts revealed a
significant linear trend in fEPSP PPR [F(1,11) = 8.972, ηp2 = 0.449] indicating paired
pulse ratios decreased linearly as inter-pulse interval increased. There was a significant
main effect of Drug [F(1,11) = 11.232, ηp2 = 0.505] indicating WIN 55,212-2 rats had
higher PPRs than vehicle rats across all submaximal stimulation inter-pulse intervals
[MVeh = 0.875, MWIN = 1.064]. Based on visual inspection of Figure 23A showing large
mean differences in fEPSP ratios at 40 ms [MVeh = 0.879, MWIN = 1.169] and 80 ms [MVeh
= 0.813, MWIN = 0.927] follow-up pairwise comparisons were conducted. WIN 55,212-2
rats had higher PPRs than vehicle rats specifically at inter-pulse intervals of 40 ms
[F(1,11) = 15.146, ηp2 = 0.579] and 80 ms [F(1,11) = 6.313, ηp2 = 0.365]. No other
effects or interactions were significant for fEPSP PPR [all ps > 0.206]. Based on these
results it is clear WIN 55,212-2 administration impacted dentate gyrus paired pulse ratios
at submaximal stimulation levels, primarily at 40 ms and 80 ms inter-pulse intervals,
indicating WIN 55,212-2 administration reduced glutamate release.
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Figure 23: Paired pulse sub-maximal responsiveness. Effect of WIN 55,212-2 on
fEPSP paired pulse ratios (A) in the dentate gyrus at three different inter-pulse intervals,
with representative traces for each group (B). Data represent group mean ± SEM. WIN
55,212-2 rats had significantly higher PPRs at 40 ms and 80 ms inter-pulse intervals (*
denotes p < 0.05).
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Paired pulse ratios at near-maximal stimulation levels
The effects of WIN 55,212-2 on dentate gyrus paired pulse ratios at near-maximal
stimulation levels at 10 ms, 20 ms, 30 ms, 40 ms, 60 ms, 80 ms, 100 ms, 200 ms, 400 ms,
600 ms, 1000 ms inter-pulse intervals are shown in Figure 24. Repeated measures
ANOVAs were conducted on PPRs with the 11 inter-pulse intervals as within-subjects
factors and fEPSP and PS measures as between-subjects factors. There was a significant
main effect of Inter-pulse Interval in both fEPSP PPR [F(10,120) = 25.679, ηp2 = 0.682]
and PS PPR [F(10,120) = 20.133, ηp2 = 0.627] indicating different inter-pulse intervals
evoked different paired pulse ratios. As expected, responses showed paired pulse
inhibition at shorter inter-pulse intervals, paired pulse facilitation at middle inter-pulse
intervals, and paired pulse inhibition at higher inter-pulse intervals (Figure 24A and 24B).
There was a significant interaction between Inter-pulse Interval X Drug [F(10,120) =
2.862, ηp2 = 0.193]. Based on visual inspection of Figure 24A showing large mean
differences in fEPSP ratios at 10 ms [MVeh = 0.668, MWIN = 0.785] and 30 ms [MVeh =
0.911, MWIN = 0.986] follow-up pairwise comparisons were conducted. WIN 55,212-2
rats had higher fEPSP PPRs than vehicle rats specifically at the inter-pulse interval of 10
ms [F(1,12) = 5.919, ηp2 = 0.330]. The fEPSP PPR difference was approaching
significant at 30 ms [F(1,12) = 4.014, p = 0.068, ηp2 = 0.251]. The PS PPR difference
was approaching significant at 10 ms [F(1,12) = 3.431, p = 0.080, ηp2 = 0.222]. No other
effects or interactions were significant for fEPSP PPR [all ps > 0.173] and PS PPR [all ps
> 0.512].

Based on these results it is clear WIN 55,212-2 administration impacted

dentate gyrus fEPSP paired pulse ratios at near-maximal stimulation levels, primarily at
10 ms inter-pulse intervals and possibly at 30 ms inter-pulse intervals. There is also some
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indication WIN 55,212-2 administration may impact PS paired pulse ratios at 10 ms
inter-pulse interval. Although these results are not as striking as sub-maximal stimulation
PPRs, there is some indication WIN 55,212-2 administration can alter GABAergic
inhibition feedback circuits within the dentate gyrus and GABA release.
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Figure 24: Paired pulse near-maximal responsiveness. Effect of WIN 55,212-2 on
fEPSP paired pulse ratios (A) and PS paired pulse ratios (B) in the dentate gyrus at eleven
different inter-pulse intervals, with representative traces for each group (C). Data
represent group mean ± SEM. WIN 55,212-2 rats had significantly higher fEPSP and PS
PPRs at 10 ms (* denotes p < 0.05). The difference was approaching significance on
fEPSP PPRs at 30 ms († denotes p = 0.068) and PS PPR at 10 ms († denotes p = 0.08).
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Long-term potentiation
The effect of WIN 55,212-2 on dentate gyrus perforant path LTP in vivo is shown
in Figure 25. Repeated measures ANOVAs were conducted on 60 minutes of post-HFS
recordings with change over time as within-subjects factors and fEPSP and PS measures
as between-subjects factors. All data was binned into one-minute intervals. Baseline
recording showed no difference between groups for fEPSP measures or PS measures (ps
> 0.753). Following HFS, there was no difference between groups in PS latency (MVeh =
-0.119, MWIN = -0.103, p = 0.342), data not shown.
During the first 5 minutes of post-HFS recordings there was a significant effect of
Drug on fEPSP [F(1,12) = 10.220, ηp2 = 0.460] indicating WIN 55,212-2 rats had higher
fEPSP average fractional change compared to vehicle rats [MVeh = 0.118, MWIN = 0.263].
WIN 55,212-2 rats had a higher increase in fEPSP from baseline following high
frequency stimulation than vehicle controls. There was also a main effect of Time on
fEPSP [F(4,48) = 22.013, ηp2 = 0.647] showing significant linear trends [F(1,12) =
32.720, ηp2 = 0.732] indicating the post-HFS response reduced over time. No other
fEPSP effects were significant (p > 0.943). During the same 5 minutes of post-HFS
recordings there were no significant differences in PS amplitude between groups (ps >
0.857).
During the entire 60 minutes of post-HFS recordings there was a significant effect
of Drug on fEPSP [F(1,12) = 5.380, ηp2 = 0.310] indicating WIN 55,212-2 rats had
higher fEPSP average fractional change compared to vehicle rats [MVeh = 0.035, MWIN =
0.158]. The difference between groups in fEPSP responses was specific to the first 24
minutes. By the end of the 60 minutes the two groups were not statistically different p =
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0.102. There was also a main effect of Time on fEPSP [F(59,708) = 4.561, ηp2 = 0.275]
showing significant quadratic trends [F(1,12) = 78.751, ηp2 = 0.868] indicating the postHFS response reduced over time. No other fEPSP effects were significant (p > 0.99).
During the same 60 minutes of post-HFS recordings there was a significant main
effect of Time in PS response [F(59,708) = 6.250, ηp2 = 0.342] both showing significant
linear trends [F(1,12) = 18.727, ηp2 = 0.609] indicating the change over time in post-HFS
response returned to baseline. No other effects or interactions were significant (ps>
0.695). The average PS fractional change between WIN 55,212-2 and vehicle rats was
similar [MVeh = 2.085, MWIN = 2.410].
Based on these results it is clear WIN 55,212-2 administration impacted fEPSP
amplitude following dentate gyrus LTP in vivo without impacting PS measures. This is
indication WIN 55,212-2 administration can alter glutamatergic responses following LTP
induction but the transient increase may decay quickly.
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Figure 25: Stimulation of the dentate gyrus perforant path in vivo. Effect of WIN
55,212-2 on fEPSP LTP response (A) and PS LTP response (B) in the dentate gyrus
following perforant path stimulation, with representative traces for each group (C). Data
represent group mean ± SEM, error bars are shown for every 10th stimulation. WIN
55,212-2 rats had significantly higher fEPSP responses following HFS compared to
vehicle rats (p < 0.05). No significant difference between groups was seen in population
spike fractional change.
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Immediate early gene expression
The effects of WIN 55,212-2 on IEG (cFos, Arc, zif268) activity following paired
pulse facilitation and long-term potentiation recordings in the dentate gyrus and parietal
cortex are shown in Figure 26. Repeated measures ANOVAs were conducted on IEG
mRNA levels with IEG (cFos, Arc, zif268) and Region (right dentate gyrus, left dentate
gyrus, parietal cortex) as within-subjects factors and Drug as between subjects factor.
The IEG Arc had a significant interaction between Region X Drug [F(2,28) =
37.118, ηp2 = 0.726]. Simple contrasts revealed that WIN 55,212-2 produced higher IEG
Arc levels in the stimulated dentate gyrus region (MVeh = 13.084, MWIN = 52.489)
compared to un-stimulated left dentate gyrus [MVeh = 0.401, MWIN = 0.450, F(1,14) =
39.020, ηp2 = 0.736] and parietal cortex [MVeh = 1.346, MWIN = 1.714, F(1,14) = 35.704,
ηp2 = 0.718]. There was a significant main effect of Region [F(2,28) = 97.865, ηp2 =
0.875]. Simple contrasts revealed the stimulated right dentate gyrus was significantly
different from the un-stimulated left dentate gyrus [F(1,14) = 105.531, ηp2 = 0.883] and
the un-stimulated parietal cortex [F(1,14) = 91.562, ηp2 = 0.867]. There was a significant
main effect of Drug [F(1,14) = 40.486, ηp2 = 0.743]. Pairwise comparisons revealed WIN
55,212-2 rats had higher levels of Arc mRNA expression compared to vehicle rats [MVeh
= 4.944, MWIN = 18.217].
The IEG cFos had a significant main effect of Region [F(2,28) = 16.894, ηp2 =
0.547]. Simple contrasts revealed the stimulated right dentate gyrus was significantly
different from the un-stimulated left dentate gyrus [F(1,14) = 35.668, ηp2 = 0.718] but not
statically different from the parietal cortex (p = 0.126). No other effects of interactions
were significant (ps > 0.584).
	
  

102	
  

	
  
	
  

For the IEG zif268, simple contrasts revealed the stimulated right dentate gyrus
was significantly different from the un-stimulated left dentate gyrus [F(1,14) = 7.113, ηp2
= 0.337] but not statically different from the parietal cortex (p = 0.984). No other effects
or interactions were significant (ps > 0.115).
When comparing LTP stimulated and un-stimulated regions of the dentate gyrus,
LTP stimulation increased all IEG mRNA expression levels, Arc [F(1,14) = 105.531, ηp2
= 0.883], cFos [F(1,14) = 35.668, ηp2 = 0.718], zif268 [F(1,14) = 7.113, ηp2 = 0.337].
However, a Stimulation X Drug interaction only occurred in Arc mRNA expression
levels [F(1,14) = 39.020, ηp2 = 0.736] indicating LTP stimulation in combination with
WIN 55,212-2 administration elevated Arc mRNA levels above Arc mRNA levels seen
with LTP stimulation alone. Based on these results it is clear WIN 55,212-2
administration elevated Arc expression in the dentate gyrus following LTP stimulation.
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Figure 26: Immediate early gene mRNA expression following dentate gyrus
perforant path stimulation in vivo. Effect of WIN 55,212-2 on IEG (Arc, cFos, zif268)
mRNA expresssion levels in the stimulated dentate gyrus (A). The remaining graphs are
divided by IEG of interest: Arc (B), cFos (C), zif268 (D) comparing un-stimulated
regions (parietal cortex control, left dentate gyrus control) to the high-frequency
stimulated right dentate gyrus. Data represent group mean (+ SEM). WIN 55,212-2 rats
had significantly higher Arc expression in the stimulated dentate gyrus compared to
vehicle rats (p <0.05). No significant differences between drug groups were seen in cFos
or zif268 expression. The stimulated dentate gyrus region had higher IEG expression
levels (Arc, cFos, zif268) compared to the non-stimulated dentate gyrus region (p <0.05).
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Discussion
The cannabinoid agonist, WIN 55,212-2, altered perforant path electrophysiology
responses in the dentate gyrus and elevated immediate early gene Arc expression within
the dentate gyrus. When taken together, these results suggest cannabinoids selectively
alter perforant path projections. The dampened population spike may be an important
factor underlying cannabinoid induced memory impairments. Based on the I/O curve
data, there is indication WIN 55,212-2 significantly blunted baseline granule cell
responsiveness due to the fact that population spike amplitude at higher current intensities
(500-600 µA) was decreased in WIN 55,212-2 rats. However, WIN 55,212-2, did not
impact baseline fEPSP responses. It has been shown that feedforward inhibition can alter
the amplitude of the population spike (Sloviter, 1991) which may partially explain the
decreased population spike seen as differences in feedforward inhibition were detected by
the cannabinoid agonist.
During paired pulse sub-maximal evaluation, by removing the population spike,
there is removal of potential GABAergic inhibitory circuitry; therefore, those PPRs are
an index of glutamate release from perforant path terminals (Varaschin, 2012). Even at
sub-maximal stimulation levels, increased PPRs reflect a reduction in the probability of
release (Zucker & Regehr, 2002). In the present study the cannabinoid agonist WIN
55,212-2 increased PPRs suggesting WIN 55,212-2 reduced the probability of glutamate
release and granule cell responsiveness.	
   At sub-maximal stimulation levels, WIN 55,2122 significantly increased fEPSP paired pulse ratios at 40 ms and 80 ms inter-pulse
intervals indicating reduced glutamate within the dentate gyrus.
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At paired pulse near-maximum levels there is evaluation of GABA release and
GABAergic feedback inhibition (Jedlicka et al., 2011; Sloviter, 1991; Varaschin, 2012).
The findings of the present study also indicate GABA mediated inhibition of dentate
granule cells is impacted by WIN 55,212-2, as higher PPRs were present. At nearmaximal stimulation levels, WIN 55,212-2 significantly increased fEPSP paired pulse
ratios at 10 ms and 30 ms, with possible indication that it may increase PS paired pulse
ratios at 10 ms as well. This indicates that WIN 55,212-2 can impair GABAergic
feedback inhibition and reduce GABA release. Together, the paired pulse measures
indicate fEPSP PPRs were impacted by WIN 55,212-2 more than PS PPRs. However, it
is a possibility that the blunted baseline population spike amplitude initially made it
difficult to detect any difference in PS PPRs. WIN 55,212-2 may influence baseline and
activity-dependent changes via different mechanisms in different inhibitory circuits.
Paired pulse protocols are often used to evaluate local circuit inhibition within the
dentate gyrus. Following granule cell excitation mossy fibers engage a feedback loop to
basket cells which leads to GABAergic inhibition of granule cells (Sloviter, 1991). The
PPR is generally greater when the initial probability of release in response to an action
potential is low. With paired pulse near-maximal stimulation levels, at short intervals (<
40 ms) the second population spike is inhibited relative to the first and this is indicative
of the degree of feedforward/recurrent inhibition occurring (Seress & Ribak, 1983;
Sloviter, 1991). At intervals between 20 and 100 ms, it has been suggested that fEPSP
PPRs reflect probability of neurotransmitter release. Given that PPR is inversely related
to the probability of neurotransmitter release, the increase in PPR at short inter-pulse
intervals by WIN 55,212-2 found here indicates a reduction in paired pulse inhibition and
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is suggestive of a reduction in GABA release during the first pulse. This is supported by
previous research showing that WIN 55,212-2 administration can decrease dialysate
GABA levels measured using microdialysis and cortical GABA levels in vivo (Ferraro et
al., 2001). In slice physiology models, cannabinoid agonists have been shown to enhance
paired pulse facilitation (Sullivan, 2000). Furthermore, CB1 knockout mice display
decreased paired pulse facilitation suggesting altered inhibitory feedback on granule cells
(Jacob, Marsch, Marsicano, Lutz, & Wotjak, 2012). Together, these findings imply the
CB1 receptor is important for regulating GABAergic feedback on granule cells. It is a
possibility that reducing feedforward inhibitory synapses would lead to increased overall
network excitation. The inhibitory impact might be disproportionate given there are fewer
interneurons than granule cells.
After high frequency stimulation of the perforant path, WIN 55,212-2
administration increased fEPSP amplitude without changing population spike amplitude.
However, the elevated fEPSP amplitude showed quick decay and was equivalent to
vehicle controls by 24 minutes post high frequency stimulation. These data were
surprising given the inhibitory nature of cannabinoid agonists. It was expected that the
cannabinoid agonist would inhibit glutamate transmission in the synapse, impairing LTP
on the post-synaptic cell. Instead, this data indicates the possibility that glutamatergic
release may be elevated temporary following high frequency stimulation.
The increase in fEPSP following LTP induction produced by WIN 55,212-2 may
be partially explained by the complexity of the current protocol, specifically, paired pulse
measures at near-maximum stimulation levels given prior to high frequency stimulation.
This high stimulation protocol may have changed the responsiveness of the granule cell.
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The current findings are unusual, because it has typically been proposed that cannabinoid
modulation within the hippocampus acts to dampen signaling and neurotransmitter
release following excitation (Sullivan, 1999, 2000). Cannabinoid receptor activation
does not directly inhibit mechanisms underlying LTP but impairs LTP by reducing
presynaptic neurotransmitter release which prevents significant depolarization to relieve
the Mg2+ blockade on NMDA receptors (Misner & Sullivan, 1999). In slice physiology
models cannabinoid agonists have been shown to impair LTP induction and enhance
paired pulse facilitation (Sullivan, 2000). Additionally, cannabinoids and CB1 receptor
signaling have been shown to be critically involved in depolarization-induced
suppression of inhibition (DSI) within CA1 pyramidal neurons (Wilson, Kunos, & Nicoll,
2001). DSI protocols involve brief trains of action potentials which transiently suppress
GABAergic neurotransmission (Pitler & Alger, 1992). Interesting, in some cases LTP
induction can be enhanced by a cannabinoid agonist if a depolarizing pulse (DSI) is given
immediately preceding high frequency stimulation (Carlson, Wang, & Alger, 2002)
because the DSI inhibits GABAergic responding allowing previously ineffective
excitatory inputs to induce LTP.

Given that changes to GABAergic inhibition can

facilitate LTP, perhaps in the present study the paired pulse facilitation protocol altered
GABAergic signaling short-term which then impacted the level of excitatory,
glutamatergic neurotransmission in LTP through a non-CB1 mechanism.
A previous study (Sokal, Benetti, Girlanda, & Large, 2008) which assessed the
impact of a cannabinoid antagonist on granule cell physiology used a complex protocol
similar to the one in this study and found similar differences in fEPSP only following
high frequency stimulation. In dentate gyrus perforant path stimulation in vivo, the
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cannabinoid antagonist SR141716A impaired fEPSP magnitude (Sokal, Benetti, et al.,
2008) without impacting the population spike amplitude compared to controls. Studies
have indicated SR141716A acts as an antagonist and inverse agonist (Pertwee, 2005).
AM 251 has also been shown to hinder fEPSP responses following LTP in CA1
pyramidal cells (Alvares et al., 2006). Sokal et al., (2008) suggest that CB1 receptors
selectively impair fEPSP responses following high frequency stimulation. They further
suggest CB1 activation in the medial perforant path increases glutamate release from
perforant terminals but inhibit GABA release from interneurons. Interestingly, Sokal and
colleagues and the present study used similar electrophysiology protocols, in that paired
pulse facilitation was measured along with LTP. Both studies found unique differences
in fEPSP magnitude following cannabinoid administration and the direction of results is
similar if you take into consideration the fact that the present study found post-HFS
elevations with a cannabinoid agonist, while Sokal and collegues found post-HFS
decreases with a cannabinoid antagonist. Also similar are the results in paired pulse
facilitation, the cannabinoid agonist used here, resulted in decreased paired pulse
inhibition, whereas, the cannabinoid antagonist resulted in increased paired pulse
inhibition. If HFS can reduce the degree of local circuit inhibition (Sokal, Benetti, et al.,
2008), perhaps PPF can also change neurotransmitter release levels prior to LTP.
The effect of cannabinoids on LTP may also vary due to the number of
stimulation trains used for LTP induction. Delta-9-tetrahydrocannabinol (THC) altered
LTP in CA1 hippocampal slices in a dose dependent manner. Nowicky et al. (1987)
found that three doses of THC resulted in a biphasic change to population spike
amplitude; a low THC dose resulted in increased baseline population spike amplitude
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while high doses of THC resulted in decreased baseline population spike amplitude prior
to LTP induction. Following high frequency stimulation, there were no differences in
LTP induction between groups, but there was a difference in LTP decay, with high doses
showing the quickest decay. These authors concluded that cannabinoids did not impact
LTP levels, or elevate LTP; instead, cannabinoids modulated the decay constant of LTP,
which could impact short-term memory processes.
Aside from altered granule cell responsiveness, WIN 55,212-2 administration
resulted in significantly higher Arc mRNA expression within the stimulated dentate gyrus
compared to vehicle controls. No differences were seen between vehicle and WIN
55,212-2 rats in cFos and zif268 expression. Unfortunately, a drug difference in zif268 in
the stimulated dentate gyrus was not detected, even though zif268 is the IEG linked to
memory consolidation and late LTP processes. Aside from drug effects, LTP stimulation
alone elevated immediate early gene expression. The dentate gyrus hemisphere that was
stimulated had increased IEG (Arc, cFos, zif268) expression levels compared to the unstimulated dentate gyrus hemisphere.
We know LTP will increase IEGs in the hippocampus. Usually increases in Arc
expression are known to facilitate learning (Guzowski, 2002; Guzowski, et al., 2000;
Guzowski, et al., 2001). Therefore, this suggest the drastic increase in Arc expression
produced by WIN 55,212-2 administration is significantly elevating plasticity within the
synapse. In one scenario this may elevate learning, but if the level of elevation is too
high, learning may be impaired. In this present study the magnitude of increase is
substantial, WIN 55,212-2 rats showed a 300% increase in Arc expression in the
stimulated dentate gyrus over controls; therefore, the synapse may be too destabilized to
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facilitate proper memory consolidation, though this is just speculation. Nonetheless, the
direction of Arc elevation in WIN 55,212-2 rats is consistent with the elevation in LTP
observed because Arc is known to be elevated following LTP protocols. While cFos,
zif268, and Arc expression appear to be important for LTP, their specific role in memory
storage is still unclear. It was expected that LTP would result in a rise in zif268
expression. It has been shown that zif268 is important for processes underlying late LTP
in the dentate gyrus (Jones, et al., 2001). Increasing the number of trains in the LTP
protocol had been correlated with increased zif268 and Fos-related proteins (Abraham, et
al., 1993). Perhaps increasing the number of trains for LTP induction from three to ten
would have resulted in a larger zif268 increase and a drug difference between groups.
A few limitations of the present study should be taken into consideration. The
present study was limited to a single, high dose of WIN 55,212-2. Future work should
explore if different doses produce similar results. Or, as observed by Nowicky et al.,
(1987) low doses may produce different results on population spike amplitude and LTP
decay than high doses of cannabinoids. Due to the fact that baseline granule cell
population spike responses in WIN 55,212-2 rats were impaired compared to controls,
there is difficulty interpreting the overall electrophysiology findings. In a potential
follow-up it would be important to artificially equalize drug rats to controls through LTP
clamping.
The current design looked at paired pulse facilitation prior to LTP induction. In
pilot work with a small animal number, alternating paired pulse protocols before and after
LTP did not impact LTP responses, but did impact the level of paired pulse inhibition.
Perhaps the paired pulse protocol before LTP also impacted LTP. Future studies should
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look at these two phenomena in a separate cohort of animals to avoid potential
confounds. Further, given the design of the current study it is difficult to infer what
triggered the rise in Arc expression in the stimulated dentate gyrus. Here, we collected
paired pulse responses for approximately an hour prior to the high frequency stimulation
hour-long protocol. It is a possibility that either or both of the paired pulse intervals or
high frequency stimulation triggered the rise the Arc in the WIN 55,212-2. Another issue
with the current design is the length of time it took to run all experimental procedures. On
average, the drug was infused into the right dentate gyrus one hour prior to paired pulse
protocols and two hours prior to the LTP protocol. It is unknown how quickly WIN
55,212-2 diffused away from its target location; therefore, it is unknown if the drug was
still present in the dentate gyrus at the end of recordings. Perhaps the rapid decay in LTP
may be explained by lack of drug at the synapse.
Additional limitations, which pertain to IEG expression, should also be taken in
consideration. This study lacked a couple additional controls for IEG analysis.
Previously, Shires and Aggleton (2008) looked at IEG correlates of hippocampaldependent learning in the MWT and concluded that problems in interpretation may arise
due to the nature of the control conditions. Here, we used the un-stimulated dentate gyrus
and parietal cortex as controls, but are lacking cage controls and a condition with
stimulation but no vehicle or drug. In Chapter 4, it was evident that the vehicle solution
by itself triggered an elevation in IEG expression; therefore, it is possible similar
elevations are occurring here. Future studies should closely examine what cell type is
responsible for the substantial increase in Arc expression. It is believed the current rise in
Arc expression is occurring within granule cells, but given that IEG mRNA levels were
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performed on homogenized dentate gyrus tissue, it is a possibility nearby cell types may
be contributing to the response. In the future, fluorescent in situ hybridization would be
able to address signaling location.
Follow-up studies should examine if there are differences in LTP following
medial versus lateral perforant path stimulation. There have been indications the medial
perforant path projection is more sensitive to the cannabinoid agonist than lateral
perforant path projections based on Golgi morphology findings (Chapter 3). Also, future
studies should pursue in-vitro slice physiology recordings in the dentate gyrus to better
control neuronal inputs and rule out elevations in endocannabinoid responding.
In summary, the present findings demonstrate that the dentate gyrus
electrophysiology and its activity related immediate early gene expression is altered by a
cannabinoid agonist microinfusion. These finding imply that cannabinoid signaling
within the dentate gyrus is very complex and the alteration in the signaling found here
may be responsible for some cannabinoid-induced memory consolidation deficits. CB1
receptors can alter GABAergic and glutamatergic signaling via feedforward and feedback
inhibition with different consequences for memory processing and memory
consolidation. WIN 55,212-2 may modulate LTP through a combined reduction of
glutamate, and GABA via feedforward and feedback processes. More research is needed
to elucidate these findings, specifically to clarify why an increase in fEPSP following
LTP was detected. By changing neurotransmitter release and signal transduction
pathways CB1 receptors may be critically involved in dampening neuronal signals to
foster forgetting naturally in the body.
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CHAPTER 6: GENERAL DISCUSSION
Summary and significance of results
The effect of a potent cannabinoid agonist, WIN 55,212-2, on rodent learning and
memory in the dentate gyrus was examined using a combination of morphological,
behavioral, electrophysiological, and gene targeting approaches. The dentate gyrus was
selected as the region of interest for its role in memory formation and consolidation
combined with its high density of CB1 receptors. The goal was to capture systems levels
phenomena (decreases in spatial memory in the MWT) down to cellular level phenomena
(difference in immediate early gene expression and neurotransmitter release). For a more
complete discussion of the findings in relation to relevant literature refer to the individual
discussions at the end of Chapters 3-5. A brief overview of the findings is presented
below.
In Chapter 3, which addressed changes to granule cell morphology following
chronic WIN 55, 212-3 administration, there was suggestion that the cannabinoid agonist
specifically alters associational-commissural projections from within the dentate gyrus
and medial perforant path projections from the entorhinal cortex. Long-term cannabinoid
administration for seven and 21 days resulted in a marked reduction in granule cell
dendritic spine density. The magnitude of spine density loss was on the order of ~1 spine
per 10 µm in dendritic segments proximal and middle to the cell body. These
observations do not reflect a generalized reduction in overall dendritic morphology, as no
differences were found between drug and vehicle groups in measures of dendritic length
and branching, but instead indicate select spine sensitivity in spatially relevant afferents
from the entorhinal cortex following long-term cannabinoid exposure. Segment specific
	
  

114	
  

	
  
	
  

changes in spine density may have important consequences for spatial learning and
memory processes in the dentate gyrus. Hargreaves et. al. (2005) showed that the medial
perforant path transferred spatial information from the medial entorhinal cortex, while the
lateral perforant path transferred nonspatial information.

The current study extends

previous adolescent findings by showing that spine loss in the dentate gyrus also occurs
in adult rats that began chronic treatment in adulthood after the brain was fully matured;
therefore, some changes in dendritic morphology following long-term cannabinoid
administration are not specific to a particular developmental age. Conversely, the fact
that we did not find differences in overall dendritic branching and length in adult rats
implies that adolescent granule cells may be more sensitive to cannabinoids. Given that
the negative consequences observed after adolescent exposure far outnumber the effects
observed after mature adulthood exposure, there is an indication that hippocampal
cannabinoid sensitivity may partially resolve by adulthood. Considering the involvement
of granule cell plasticity in memory, these observations suggest exposure to exogenous
cannabinoids can have profound and long-lasting consequences on long-term spatial
memory storage and consolidation.
In Chapter 4, which focused on 24-hour MWT consolidation deficits following
microinfusion of WIN 55,212-2 in the dentate gyrus, there was suggestion that CB1
receptor activation in the dentate gyrus alone is insufficient to create a memory deficit.
Prior work from our laboratory found WIN 55,212-2 given post-training resulted in
retention deficits following a 24-hour consolidation time frame (Candelaria-Cook, 2009;
Candelaria-Cook & Hamilton, 2008). This memory consolidation deficit could be
recovered by administration of the cannabinoid antagonist AM 251 (Candelaria-Cook &

	
  

115	
  

	
  
	
  

Hamilton, 2010), further supporting the role of CB1 receptors in spatial memory
consolidation. In contrast, the present study found that direct infusion of WIN 55,212-2
into the dentate gyrus did not influence 24-hour memory consolidation or alter immediate
early gene expression in the dentate gyrus or parietal cortex. This indicates that another
region of the hippocampal formation, or the summation of all hippocampal areas working
together is responsible for proper memory consolidation following cannabinoid
administration. The present study also found that the cannabinoid antagonist AM 251
followed 30 minutes later by the cannabinoid agonist WIN 55,212-2 resulted in impaired
MWT probe retention 24 hours following training. Considering the unexpected nature of
this drug effect, the drug dosing used in this protocol may need to be modified. The role
of the dentate gyrus in spatial memory consolidation can be debated. Previous research
by Okada & Okaichi (2009) has shown that the hippocampus is a functional unit for
spatial memory and a certain degree of cooperation between subregions is necessary for
proper memory storage. Further, lesions to the dentate gyrus, CA3, and CA1 cause
varying degrees of impairment in MWT acquisition depending on if the hippocampal
commissure was also severed. This indicates that the associational-commissural pathway
is critical to maintaining proper spatial memory consolidation as it relays spatial
information between subregions on unilateral and contralateral sides. It is also necessary
to consider what memory phase was being studied. Post-training drug infusion and
consolidation require different hippocampal subregions than acquisition.

For MWT

acquisition, rats can still learn the task with as little as a quarter of the dorsal
hippocampus intact (Moser, et al., 1995). However, two-thirds of the dorsal hippocampus
is necessary for memory retrieval, when tested with lesions and muscimol temporary

	
  

116	
  

	
  
	
  

inactivation (Moser & Moser, 1998a, 1998b). The complexity and redundancy present in
hippocampal networks is resilient enough to endure partial subregion deactivations and
lesions without impaired spatial memory.
In Chapter 5, which focused on changes in perforant path to dentate gyrus
electrophysiology following microinfusion of WIN 55,212-2, there was suggestion that
cannabinoid modulation via GABAergic feedforward inhibition results in reduced
glutamate release and corresponding elevation in the mRNA levels of the immediate
early gene Arc. WIN 55,212-2 blunted the magnitude of baseline population spike
amplitude at current intensities between 500-600 µA, without impacting baseline fEPSP
response. The cannabinoid agonist also altered fEPSP paired pulse ratios indicating
decreased glutamate release and altered GABAergic inhibition via feedforward
projections. Together, the paired pulse measures indicate fEPSP PPRs were impacted by
WIN 55,212-2 more than PS PPRs. However, it is a possibility that the blunted baseline
population spike amplitude initially made it difficult to detect any difference in PS PPRs.
WIN 55,212-2 may alter baseline and activity-dependent changes via different
mechanisms in different inhibitory circuits. Following high frequency stimulation WIN
55,212-2 also increased fEPSP amplitude transiently. This indicates the possibility that
glutamatergic release may be elevated temporary following high frequency stimulation,
but given the lack of support in the literature for this finding, more research is needed to
clarify this result, as it may not replicate with a different protocol design. And lastly,
WIN 55,212-2 rats resulted in elevated Arc immediate early gene expression in the
stimulated dentate gyrus.

WIN 55,212-2 may modulate LTP through a combined

reduction of glutamate and GABA via feedforward and feedback processes. When taken
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together, these results suggest cannabinoids selectively alter the perforant path projection.
However, the reduced baseline granule cell population spike amplitude and altered
GABA mediated feedback inhibition may be important factors underlying cannabinoid
induced memory impairments.
Critique and future studies
Although these experiments were carefully designed, there are several limitations
of each which need to be considered when interpreting the results found. First, all studies
used a high drug dose of WIN 55,212-2. It is known that WIN 55,212-2 is a potent
cannabinoid agonist but its exact half-life and metabolism are largely unknown. Moving
forward a proper dose-response curve and half-life metabolism should be investigated.
These would aide greatly in the analysis of results produced by the WIN 55,212-2
cannabinoid agonist.

Second, throughout most of these experiments, better control

conditions could be added. Most of the needed controls would address changes in
immediate early gene expression evoked by changes in various behaviors and activity.
There was indication that the vehicle alone elevated immediate early genes above
baseline, therefore, having additional baseline controls would be useful. There were other
limitations of each design but for complete description refer to the end of each chapter
discussion.
Final remarks
When taken together, these findings partially clarify ways in which cannabinoids
are detrimental to long-term memory formation, consolidation and storage in the brain.
Cannabinoids alter normal learning and memory processes in the dentate gyrus by
selectively altering medial perforant path projections, influencing GABAergic
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feedforward inhibition, reducing glutamate release, and increasing expression of the
immediate early gene Arc. Cannabinoid modulation throughout the dentate gyrus and
other hippocampal subregions are necessary for memory consolidation processes.

	
  

119	
  

	
  
	
  

LIST OF ABBREVIATIONS
2-AG

2-Arachidonoylglycerol268)

A-CP

Associational-commissural projection

AM 251

1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-(1piperidyl)pyrazole-3-carboxamide

ANOVA

Analysis of Variance

CA1

Cornu Ammonis area 1

CA3

Cornu Ammonis area 3

CB1

Cannabinoid Receptor subtype 1

CB2

Cannabinoid Receptor subtype 2

DAG

Diacylglycerol

DG

Dentate gyrus

DMSO

Dimethyl sulfoxide

ES40

Effective stimulus intensity to elicit 40% of maximal
response

fEPSP

Field excitatory postsynaptic potential

GABA

Gamma-Aminobutyric acid

HFS

High frequency stimulation

IEG

Immediate early gene

i.p.

Intraperitoneal

I/O

Input/Output

LPP

Lateral perforant path

LTD

Long-term depression
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LTP

Long-term potentiation

MPP

Medial perforant path

mGluR

Metabotropic glutamate receptor

mRNA

Messenger ribonucleic acid

NMDA

N-methyl-D-aspartate

MWT

Morris water task

PPR

Paired-pulse ratio

PPF

Paired-pulse facilitation

PS

Population spike

RT-PCR

Real time polymerase chain reaction

THC

delta-9-tetrahydrocannabinol

WIN 55,212-2

[R-(+)-(2,3-dihydro-5-methyl-3-[{4-morpholinyl} methyl]
pyrol[1,2,3-de-]-1,4-benzoxazin-6-yl)(1-naphthalenyl)methanone mesylate]	
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